KR20150050234A - Composition containing octyl gallate - Google Patents
Composition containing octyl gallate Download PDFInfo
- Publication number
- KR20150050234A KR20150050234A KR1020130131769A KR20130131769A KR20150050234A KR 20150050234 A KR20150050234 A KR 20150050234A KR 1020130131769 A KR1020130131769 A KR 1020130131769A KR 20130131769 A KR20130131769 A KR 20130131769A KR 20150050234 A KR20150050234 A KR 20150050234A
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- octyl gallate
- composition
- salts
- polyethylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 214
- 235000010387 octyl gallate Nutrition 0.000 title claims abstract description 113
- 239000000574 octyl gallate Substances 0.000 title claims abstract description 111
- NRPKURNSADTHLJ-UHFFFAOYSA-N octyl gallate Chemical compound CCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 NRPKURNSADTHLJ-UHFFFAOYSA-N 0.000 title claims abstract description 110
- 239000003755 preservative agent Substances 0.000 claims abstract description 65
- 230000002335 preservative effect Effects 0.000 claims abstract description 57
- 239000002537 cosmetic Substances 0.000 claims abstract description 53
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 37
- 239000003814 drug Substances 0.000 claims abstract description 15
- 229940079593 drug Drugs 0.000 claims abstract description 15
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 9
- -1 2-hydroxybiphenyl ether Chemical compound 0.000 claims description 77
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 37
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 36
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 34
- 150000003839 salts Chemical class 0.000 claims description 29
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 20
- 150000002148 esters Chemical class 0.000 claims description 20
- 239000004480 active ingredient Substances 0.000 claims description 19
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 17
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 15
- 235000013772 propylene glycol Nutrition 0.000 claims description 12
- 239000004599 antimicrobial Substances 0.000 claims description 10
- 230000001965 increasing effect Effects 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000004202 carbamide Substances 0.000 claims description 9
- 239000005711 Benzoic acid Substances 0.000 claims description 8
- 235000010233 benzoic acid Nutrition 0.000 claims description 8
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 7
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 229960003260 chlorhexidine Drugs 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 6
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 6
- TYBHZVUFOINFDV-UHFFFAOYSA-N 2-bromo-6-[(3-bromo-5-chloro-2-hydroxyphenyl)methyl]-4-chlorophenol Chemical compound OC1=C(Br)C=C(Cl)C=C1CC1=CC(Cl)=CC(Br)=C1O TYBHZVUFOINFDV-UHFFFAOYSA-N 0.000 claims description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 claims description 4
- WKPFIJAMMDLXDI-UHFFFAOYSA-N 1,2-thiazolidin-4-one Chemical compound O=C1CNSC1 WKPFIJAMMDLXDI-UHFFFAOYSA-N 0.000 claims description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 3
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 3
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 3
- 229960005323 phenoxyethanol Drugs 0.000 claims description 3
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 3
- 235000019260 propionic acid Nutrition 0.000 claims description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 3
- 239000004334 sorbic acid Substances 0.000 claims description 3
- 235000010199 sorbic acid Nutrition 0.000 claims description 3
- 229940075582 sorbic acid Drugs 0.000 claims description 3
- KDLNSPFOKWMQQM-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-2-amine Chemical compound CCCCC(CC)CN1CC(C)CN(CC(CC)CCCC)C1N KDLNSPFOKWMQQM-UHFFFAOYSA-N 0.000 claims description 2
- DBHODFSFBXJZNY-UHFFFAOYSA-N 2,4-dichlorobenzyl alcohol Chemical compound OCC1=CC=C(Cl)C=C1Cl DBHODFSFBXJZNY-UHFFFAOYSA-N 0.000 claims description 2
- ZSMKZRXHCAOERY-UHFFFAOYSA-N 3-bromo-4-[6-(2-bromo-4-carbamimidoylphenoxy)hexoxy]benzenecarboximidamide Chemical compound BrC1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1Br ZSMKZRXHCAOERY-UHFFFAOYSA-N 0.000 claims description 2
- GUQMDNQYMMRJPY-UHFFFAOYSA-N 4,4-dimethyl-1,3-oxazolidine Chemical compound CC1(C)COCN1 GUQMDNQYMMRJPY-UHFFFAOYSA-N 0.000 claims description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 claims description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims description 2
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 2
- 239000005083 Zinc sulfide Substances 0.000 claims description 2
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 claims description 2
- VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 claims description 2
- 229960004698 dichlorobenzyl alcohol Drugs 0.000 claims description 2
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 claims description 2
- HXQVQGWHFRNKMS-UHFFFAOYSA-M ethylmercurithiosalicylic acid Chemical compound CC[Hg]SC1=CC=CC=C1C(O)=O HXQVQGWHFRNKMS-UHFFFAOYSA-M 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 229940050410 gluconate Drugs 0.000 claims description 2
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 claims description 2
- 239000004312 hexamethylene tetramine Substances 0.000 claims description 2
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N ortho-phenyl-phenol Natural products OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 claims description 2
- 235000010292 orthophenyl phenol Nutrition 0.000 claims description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 2
- 229920002866 paraformaldehyde Polymers 0.000 claims description 2
- 229940096825 phenylmercury Drugs 0.000 claims description 2
- DCNLOVYDMCVNRZ-UHFFFAOYSA-N phenylmercury(.) Chemical compound [Hg]C1=CC=CC=C1 DCNLOVYDMCVNRZ-UHFFFAOYSA-N 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- CITBNDNUEPMTFC-UHFFFAOYSA-M sodium;2-(hydroxymethylamino)acetate Chemical compound [Na+].OCNCC([O-])=O CITBNDNUEPMTFC-UHFFFAOYSA-M 0.000 claims description 2
- AISMNBXOJRHCIA-UHFFFAOYSA-N trimethylazanium;bromide Chemical compound Br.CN(C)C AISMNBXOJRHCIA-UHFFFAOYSA-N 0.000 claims description 2
- 229910052984 zinc sulfide Inorganic materials 0.000 claims description 2
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 claims 2
- NCKMMSIFQUPKCK-UHFFFAOYSA-N 2-benzyl-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1CC1=CC=CC=C1 NCKMMSIFQUPKCK-UHFFFAOYSA-N 0.000 claims 1
- YSEYOMUPVMGJPP-UHFFFAOYSA-N 3-chloro-2-methylpyridine Chemical compound CC1=NC=CC=C1Cl YSEYOMUPVMGJPP-UHFFFAOYSA-N 0.000 claims 1
- ZRCMGIXRGFOXNT-UHFFFAOYSA-N 7a-ethyl-1,3,5,7-tetrahydro-[1,3]oxazolo[3,4-c][1,3]oxazole Chemical compound C1OCN2COCC21CC ZRCMGIXRGFOXNT-UHFFFAOYSA-N 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 1
- 241000233866 Fungi Species 0.000 abstract description 15
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 14
- 238000004321 preservation Methods 0.000 abstract description 10
- 239000003242 anti bacterial agent Substances 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 229940121375 antifungal agent Drugs 0.000 abstract description 2
- 239000003429 antifungal agent Substances 0.000 abstract description 2
- 239000003206 sterilizing agent Substances 0.000 abstract description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 97
- 239000002202 Polyethylene glycol Substances 0.000 description 96
- 239000000839 emulsion Substances 0.000 description 56
- 230000002195 synergetic effect Effects 0.000 description 47
- 244000005700 microbiome Species 0.000 description 43
- 229920001817 Agar Polymers 0.000 description 30
- 239000008272 agar Substances 0.000 description 30
- 235000014113 dietary fatty acids Nutrition 0.000 description 28
- 239000000194 fatty acid Substances 0.000 description 28
- 229930195729 fatty acid Natural products 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- 239000000126 substance Substances 0.000 description 26
- 238000002360 preparation method Methods 0.000 description 23
- 239000011734 sodium Substances 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 20
- 229910052708 sodium Inorganic materials 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- 150000001875 compounds Chemical class 0.000 description 19
- 210000002615 epidermis Anatomy 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 241000228212 Aspergillus Species 0.000 description 16
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical class C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 16
- 239000003921 oil Substances 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 150000001298 alcohols Chemical class 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 150000004665 fatty acids Chemical class 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 12
- 229920006395 saturated elastomer Polymers 0.000 description 12
- 241000186146 Brevibacterium Species 0.000 description 11
- 241000186216 Corynebacterium Species 0.000 description 11
- 241000186427 Cutibacterium acnes Species 0.000 description 11
- 239000003995 emulsifying agent Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 11
- 229940055019 propionibacterium acne Drugs 0.000 description 11
- 229960004063 propylene glycol Drugs 0.000 description 11
- 239000000725 suspension Substances 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 238000011081 inoculation Methods 0.000 description 10
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical class CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 10
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 9
- LQXBZWFNAKZUNM-UHFFFAOYSA-N 16-methyl-1-(16-methylheptadecoxy)heptadecane Chemical compound CC(C)CCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC(C)C LQXBZWFNAKZUNM-UHFFFAOYSA-N 0.000 description 9
- 241001480035 Epidermophyton Species 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 9
- 150000007513 acids Chemical class 0.000 description 9
- 150000002170 ethers Chemical class 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 8
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 8
- OUUCZGCOAXRCHN-UHFFFAOYSA-N 1-hexadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC OUUCZGCOAXRCHN-UHFFFAOYSA-N 0.000 description 8
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 8
- 239000003945 anionic surfactant Substances 0.000 description 8
- 239000006071 cream Substances 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 239000003925 fat Substances 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 150000002191 fatty alcohols Chemical class 0.000 description 8
- 229940049964 oleate Drugs 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 7
- 239000000419 plant extract Substances 0.000 description 7
- 229920002545 silicone oil Polymers 0.000 description 7
- 239000001993 wax Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 239000003093 cationic surfactant Substances 0.000 description 6
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 6
- 229920000053 polysorbate 80 Polymers 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 239000002736 nonionic surfactant Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000002255 vaccination Methods 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 4
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 4
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 239000002280 amphoteric surfactant Substances 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 150000002009 diols Chemical class 0.000 description 4
- 229940074046 glyceryl laurate Drugs 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- 229940031723 1,2-octanediol Drugs 0.000 description 3
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- DHVLDKHFGIVEIP-UHFFFAOYSA-N 2-bromo-2-(bromomethyl)pentanedinitrile Chemical compound BrCC(Br)(C#N)CCC#N DHVLDKHFGIVEIP-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 241001116389 Aloe Species 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 208000035985 Body Odor Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical class [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 206010040904 Skin odour abnormal Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 240000007313 Tilia cordata Species 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 235000011399 aloe vera Nutrition 0.000 description 3
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 3
- 230000003042 antagnostic effect Effects 0.000 description 3
- 239000003125 aqueous solvent Substances 0.000 description 3
- 150000007942 carboxylates Chemical class 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 229940106189 ceramide Drugs 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 229940086555 cyclomethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 150000002430 hydrocarbons Chemical group 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- QAOJADINKLMTRR-UHFFFAOYSA-N octan-3-yl 16-methylheptadecanoate Chemical compound CCCCCC(CC)OC(=O)CCCCCCCCCCCCCCC(C)C QAOJADINKLMTRR-UHFFFAOYSA-N 0.000 description 3
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000011591 potassium Chemical class 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 125000005555 sulfoximide group Chemical group 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical class CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 2
- QNESDXMHQYMNGD-UHFFFAOYSA-N 2,3-bis(3,5,5-trimethylhexanoyloxy)propyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CC(=O)OCC(OC(=O)CC(C)CC(C)(C)C)COC(=O)CC(C)CC(C)(C)C QNESDXMHQYMNGD-UHFFFAOYSA-N 0.000 description 2
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical group COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- ZFGOPJASRDDARH-UHFFFAOYSA-N 3-[[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C(C2)C1(C)CCC2OC1CC2=CCC3C4CCC(C(C)CCCC(C)C)C4(C)CCC3C2(C)CC1 ZFGOPJASRDDARH-UHFFFAOYSA-N 0.000 description 2
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- 240000000073 Achillea millefolium Species 0.000 description 2
- 235000007754 Achillea millefolium Nutrition 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- 240000005528 Arctium lappa Species 0.000 description 2
- 235000003130 Arctium lappa Nutrition 0.000 description 2
- 235000008078 Arctium minus Nutrition 0.000 description 2
- 241000208983 Arnica Species 0.000 description 2
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000005881 Calendula officinalis Nutrition 0.000 description 2
- 240000003538 Chamaemelum nobile Species 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- 244000103926 Chamaenerion angustifolium Species 0.000 description 2
- 235000008302 Chamaenerion angustifolium Nutrition 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 229920004511 Dow Corning® 200 Fluid Polymers 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000191070 Escherichia coli ATCC 8739 Species 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 244000305267 Quercus macrolepis Species 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 241000124033 Salix Species 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 240000000785 Tagetes erecta Species 0.000 description 2
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 235000009108 Urtica dioica Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 229940071160 cocoate Drugs 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 229940079886 disodium lauryl sulfosuccinate Drugs 0.000 description 2
- KHIQYZGEUSTKSB-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O.CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O KHIQYZGEUSTKSB-UHFFFAOYSA-L 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 2
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- LBQIJVLKGVZRIW-ZDUSSCGKSA-N glabridin Chemical compound C1([C@H]2CC3=CC=C4OC(C=CC4=C3OC2)(C)C)=CC=C(O)C=C1O LBQIJVLKGVZRIW-ZDUSSCGKSA-N 0.000 description 2
- 229940093767 glabridin Drugs 0.000 description 2
- PMPYOYXFIHXBJI-ZDUSSCGKSA-N glabridin Natural products C1([C@H]2CC=3C=CC4=C(C=3OC2)CCC(O4)(C)C)=CC=C(O)C=C1O PMPYOYXFIHXBJI-ZDUSSCGKSA-N 0.000 description 2
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 description 2
- 150000002314 glycerols Chemical class 0.000 description 2
- 229940074052 glyceryl isostearate Drugs 0.000 description 2
- 229940100242 glycol stearate Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- ZUBZATZOEPUUQF-UHFFFAOYSA-N isononane Chemical compound CCCCCCC(C)C ZUBZATZOEPUUQF-UHFFFAOYSA-N 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229940056211 paraffin Drugs 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- LKUNXBRZDFMZOK-UHFFFAOYSA-N rac-1-monodecanoylglycerol Chemical compound CCCCCCCCCC(=O)OCC(O)CO LKUNXBRZDFMZOK-UHFFFAOYSA-N 0.000 description 2
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- WVYADZUPLLSGPU-UHFFFAOYSA-N salsalate Chemical compound OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O WVYADZUPLLSGPU-UHFFFAOYSA-N 0.000 description 2
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 2
- 229940057429 sorbitan isostearate Drugs 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229940035936 ubiquinone Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- CMPDALZGFSCNOU-UHFFFAOYSA-N (2-hydroxy-3-methylphenyl)-phenylmethanone Chemical compound CC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O CMPDALZGFSCNOU-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- PDHSAQOQVUXZGQ-JKSUJKDBSA-N (2r,3s)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2h-chromene-5,7-diol Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2OC)=CC=C(O)C(O)=C1 PDHSAQOQVUXZGQ-JKSUJKDBSA-N 0.000 description 1
- AALXZHPCKJILAZ-UHFFFAOYSA-N (4-propan-2-ylphenyl)methyl 2-hydroxybenzoate Chemical compound C1=CC(C(C)C)=CC=C1COC(=O)C1=CC=CC=C1O AALXZHPCKJILAZ-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- YAYNEUUHHLGGAH-UHFFFAOYSA-N 1-chlorododecane Chemical compound CCCCCCCCCCCCCl YAYNEUUHHLGGAH-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- HFZWRUODUSTPEG-UHFFFAOYSA-N 2,4-dichlorophenol Chemical compound OC1=CC=C(Cl)C=C1Cl HFZWRUODUSTPEG-UHFFFAOYSA-N 0.000 description 1
- AOHBGMDQHXJADT-UHFFFAOYSA-N 2-(2-dodecanoyloxypropanoyloxy)propanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C(O)=O AOHBGMDQHXJADT-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- OJCFEGKCRWEVSN-UHFFFAOYSA-N 2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCO OJCFEGKCRWEVSN-UHFFFAOYSA-N 0.000 description 1
- HJDITXMCJQRQLU-UHFFFAOYSA-N 2-[dodecanoyl(methyl)amino]acetate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCC(=O)N(C)CC(O)=O HJDITXMCJQRQLU-UHFFFAOYSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N 2-amino-4-methylselanyl-butanoic acid Chemical compound C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- DXPQDAHFCMBFMM-UHFFFAOYSA-N 2-benzoylbenzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1C(=O)C1=CC=CC=C1 DXPQDAHFCMBFMM-UHFFFAOYSA-N 0.000 description 1
- KXTAOXNYQGASTA-UHFFFAOYSA-N 2-benzylidenepropanedioic acid Chemical compound OC(=O)C(C(O)=O)=CC1=CC=CC=C1 KXTAOXNYQGASTA-UHFFFAOYSA-N 0.000 description 1
- NAGVKZOTMXGCCA-UHFFFAOYSA-N 2-ethylhexyl 7-methyloctanoate Chemical compound CCCCC(CC)COC(=O)CCCCCC(C)C NAGVKZOTMXGCCA-UHFFFAOYSA-N 0.000 description 1
- UADWUILHKRXHMM-UHFFFAOYSA-N 2-ethylhexyl benzoate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1 UADWUILHKRXHMM-UHFFFAOYSA-N 0.000 description 1
- 229940106004 2-ethylhexyl benzoate Drugs 0.000 description 1
- LWLRMRFJCCMNML-UHFFFAOYSA-N 2-ethylhexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CC)CCCC LWLRMRFJCCMNML-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- MWKPHOIHTLQZIY-UHFFFAOYSA-N 2-hexyldecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC MWKPHOIHTLQZIY-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- RUDXBXPTJPNTSO-UHFFFAOYSA-N 2-octyldodecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC RUDXBXPTJPNTSO-UHFFFAOYSA-N 0.000 description 1
- DUUKZBGYNMHUHO-UHFFFAOYSA-N 253MC0P0YV Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)CO DUUKZBGYNMHUHO-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- OEOIWYCWCDBOPA-UHFFFAOYSA-N 6-methyl-heptanoic acid Chemical compound CC(C)CCCCC(O)=O OEOIWYCWCDBOPA-UHFFFAOYSA-N 0.000 description 1
- SJIDAAGFCNIAJP-UHFFFAOYSA-N 6-methylheptyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCC(C)C SJIDAAGFCNIAJP-UHFFFAOYSA-N 0.000 description 1
- LQAMWLCPFJZSSU-UHFFFAOYSA-N 7a-ethyl-1,3,5,7-tetrahydro-[1,3]oxazolo[3,4-c][1,3]oxazole;pentanedial Chemical compound O=CCCCC=O.C1OCN2COCC21CC LQAMWLCPFJZSSU-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 235000006578 Althaea Nutrition 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 108030001720 Bontoxilysin Proteins 0.000 description 1
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- LKUNXBRZDFMZOK-GFCCVEGCSA-N Capric acid monoglyceride Natural products CCCCCCCCCC(=O)OC[C@H](O)CO LKUNXBRZDFMZOK-GFCCVEGCSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 241000159174 Commiphora Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- LAAPRQODJPXAHC-UHFFFAOYSA-N Coniferyl benzoate Natural products C1=C(O)C(OC)=CC(C=CCOC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- AXGRCZMRSSHAML-UHFFFAOYSA-N Euxyl K 400 Chemical compound CC(O)Oc1ccccc1.CC(O)Oc1ccccc1.CC(O)Oc1ccccc1.CC(O)Oc1ccccc1.BrCC(Br)(CCC#N)C#N AXGRCZMRSSHAML-UHFFFAOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 244000130592 Hibiscus syriacus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000520028 Lamium Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 241000555688 Malassezia furfur Species 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 235000007171 Ononis arvensis Nutrition 0.000 description 1
- 240000002598 Ononis spinosa Species 0.000 description 1
- 235000016054 Ononis spinosa subsp spinosa Nutrition 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 235000005205 Pinus Nutrition 0.000 description 1
- 241000218602 Pinus <genus> Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 241000350481 Pterogyne nitens Species 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- 101000611641 Rattus norvegicus Protein phosphatase 1 regulatory subunit 15A Proteins 0.000 description 1
- 241000219053 Rumex Species 0.000 description 1
- ARCJQKUWGAZPFX-KBPBESRZSA-N S-trans-stilbene oxide Chemical compound C1([C@H]2[C@@H](O2)C=2C=CC=CC=2)=CC=CC=C1 ARCJQKUWGAZPFX-KBPBESRZSA-N 0.000 description 1
- 239000006159 Sabouraud's agar Substances 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000000377 Tussilago farfara Species 0.000 description 1
- 235000004869 Tussilago farfara Nutrition 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 241000218215 Urticaceae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- NENOAJSZZPODGJ-OIMNJJJWSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octanoate Chemical compound CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NENOAJSZZPODGJ-OIMNJJJWSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940098323 ammonium cocoyl isethionate Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940111131 antiinflammatory and antirheumatic product propionic acid derivative Drugs 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000012237 artificial material Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 230000011681 asexual reproduction Effects 0.000 description 1
- 238000013465 asexual reproduction Methods 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 210000001099 axilla Anatomy 0.000 description 1
- WXQWKYFPCLREEY-UHFFFAOYSA-N azane;ethanol Chemical class N.CCO.CCO.CCO WXQWKYFPCLREEY-UHFFFAOYSA-N 0.000 description 1
- WOIIIUDZSOLAIW-NSHDSACASA-N azapropazone Chemical compound C1=C(C)C=C2N3C(=O)[C@H](CC=C)C(=O)N3C(N(C)C)=NC2=C1 WOIIIUDZSOLAIW-NSHDSACASA-N 0.000 description 1
- 229960001671 azapropazone Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- UADWUILHKRXHMM-ZDUSSCGKSA-N benzoflex 181 Natural products CCCC[C@H](CC)COC(=O)C1=CC=CC=C1 UADWUILHKRXHMM-ZDUSSCGKSA-N 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229940053031 botulinum toxin Drugs 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000010957 calcium stearoyl-2-lactylate Nutrition 0.000 description 1
- OEUVSBXAMBLPES-UHFFFAOYSA-L calcium stearoyl-2-lactylate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O.CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O OEUVSBXAMBLPES-UHFFFAOYSA-L 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940056318 ceteth-20 Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical compound CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- 229960004830 cetylpyridinium Drugs 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical class CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- MXOAEAUPQDYUQM-UHFFFAOYSA-N chlorphenesin Chemical compound OCC(O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-UHFFFAOYSA-N 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000006781 columbia blood agar Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- LAAPRQODJPXAHC-AATRIKPKSA-N coniferyl benzoate Chemical compound C1=C(O)C(OC)=CC(\C=C\COC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-AATRIKPKSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 229910052878 cordierite Inorganic materials 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- QSAWQNUELGIYBC-UHFFFAOYSA-N cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCC1C(O)=O QSAWQNUELGIYBC-UHFFFAOYSA-N 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- VQODGRNSFPNSQE-CXSFZGCWSA-N dexamethasone phosphate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)COP(O)(O)=O)(O)[C@@]1(C)C[C@@H]2O VQODGRNSFPNSQE-CXSFZGCWSA-N 0.000 description 1
- 229960004833 dexamethasone phosphate Drugs 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- LVYZJEPLMYTTGH-UHFFFAOYSA-H dialuminum chloride pentahydroxide dihydrate Chemical compound [Cl-].[Al+3].[OH-].[OH-].[Al+3].[OH-].[OH-].[OH-].O.O LVYZJEPLMYTTGH-UHFFFAOYSA-H 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 239000002283 diesel fuel Substances 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical class OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- JSKIRARMQDRGJZ-UHFFFAOYSA-N dimagnesium dioxido-bis[(1-oxido-3-oxo-2,4,6,8,9-pentaoxa-1,3-disila-5,7-dialuminabicyclo[3.3.1]nonan-7-yl)oxy]silane Chemical compound [Mg++].[Mg++].[O-][Si]([O-])(O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2)O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2 JSKIRARMQDRGJZ-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 229940105576 disalcid Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical class N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- PASCYLAFGHJSHW-UHFFFAOYSA-N ethyl 2-[(4-methoxyphenyl)methyl]-3-(methylamino)propanoate Chemical compound CCOC(=O)C(CNC)CC1=CC=C(OC)C=C1 PASCYLAFGHJSHW-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229940020356 folic acid and derivative as antianemic Drugs 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940080812 glyceryl caprate Drugs 0.000 description 1
- 229940087068 glyceryl caprylate Drugs 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 229940068939 glyceryl monolaurate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940074050 glyceryl myristate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 229940113096 isoceteth 20 Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940051810 licorice root extract Drugs 0.000 description 1
- 235000020725 licorice root extract Nutrition 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960000649 oxyphenbutazone Drugs 0.000 description 1
- HFHZKZSRXITVMK-UHFFFAOYSA-N oxyphenbutazone Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 HFHZKZSRXITVMK-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- LXTZRIBXKVRLOA-UHFFFAOYSA-N padimate a Chemical compound CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 LXTZRIBXKVRLOA-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000024241 parasitism Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 description 1
- 229960001807 prilocaine Drugs 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- PZQSQRCNMZGWFT-QXMHVHEDSA-N propan-2-yl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C PZQSQRCNMZGWFT-QXMHVHEDSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- MILWSGRFEGYSGM-UHFFFAOYSA-N propane-1,2-diol;propane-1,2,3-triol Chemical compound CC(O)CO.OCC(O)CO MILWSGRFEGYSGM-UHFFFAOYSA-N 0.000 description 1
- 150000005599 propionic acid derivatives Chemical class 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 229940026235 propylene glycol monolaurate Drugs 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000012449 sabouraud dextrose agar Substances 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000014639 sexual reproduction Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940080230 sodium c12-14 olefin sulfonate Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 description 1
- BCISDMIQYBCHAT-UHFFFAOYSA-M sodium;2-(dodecanoylamino)ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCCS([O-])(=O)=O BCISDMIQYBCHAT-UHFFFAOYSA-M 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000002294 steroidal antiinflammatory agent Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- ARCJQKUWGAZPFX-UHFFFAOYSA-N stilbene oxide Chemical compound O1C(C=2C=CC=CC=2)C1C1=CC=CC=C1 ARCJQKUWGAZPFX-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 150000003458 sulfonic acid derivatives Chemical class 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960001017 tolmetin Drugs 0.000 description 1
- UPSPUYADGBWSHF-UHFFFAOYSA-N tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- GAAKLDANOSASAM-UHFFFAOYSA-N undec-10-enoic acid;zinc Chemical compound [Zn].OC(=O)CCCCCCCCC=C GAAKLDANOSASAM-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 150000003754 zirconium Chemical class 0.000 description 1
- 150000003755 zirconium compounds Chemical class 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
- A01N31/16—Oxygen or sulfur directly attached to an aromatic ring system with two or more oxygen or sulfur atoms directly attached to the same aromatic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Birds (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 옥틸 갈레이트를 포함하는 화장료 조성물, 의약외품 조성물, 방부제 조성물, 항균 조성물 및 약학적 조성물에 관한 것이다. 본 발명에 따른 옥틸 갈레이트를 항균 상승 효과의 목적으로 사용하여 다양한 균들에 대한 폭넓은 항균활성 스펙트럼을 나타낼 수 있으므로 이를 포함하는 조성물은 화장품, 의약, 생활용품, 농약 등 다양한 분야에서 살균, 항균, 방부목적으로 유용하게 이용가능하다.The present invention relates to cosmetic compositions, quasi-drug compositions, preservative compositions, antimicrobial compositions and pharmaceutical compositions comprising octyl gallate. Since the octyl gallate according to the present invention can be used for the purpose of enhancing the antimicrobial activity, it can exhibit a broad spectrum of antimicrobial activity against various fungi. Therefore, the composition containing the same can be used as a sterilizing, antibacterial and antifungal agent in various fields such as cosmetics, medicines, It is useful for preservation purposes.
Description
본 발명은 옥틸 갈레이트를 포함하는 화장료 조성물, 의약외품 조성물, 방부제 조성물, 항균 조성물 및 약학적 조성물에 관한 것이다. The present invention relates to cosmetic compositions, quasi-drug compositions, preservative compositions, antimicrobial compositions and pharmaceutical compositions comprising octyl gallate.
요즈음 교통의 발달로 전 세계적인 이동이 활발하고 이로 인해 사람의 이동을 따라 여러가지 전염성 질환이나 신규 질환이 급속도로 퍼지고 있다. 그동안 무분별한 항균 물질의 사용으로 여러 미생물들이 내성을 가지게 되어 인류를 위협하고 있다. 특히, 부패성의 제품(예를 들면 화장품, 의약품 혹은 식품)의 보존을 위해서 신체에 악영향을 끼칠 가능성이 있는 미생물에 대한 직접적인 미용적 개선 혹은 치료요법을 위한 항균성을 가지는 물질의 수요가 계속해 존재한다.Due to the development of traffic these days, global movement is active, and various infectious diseases and new diseases are rapidly spreading along with human movement. In the meantime, the use of indiscriminate antimicrobial agents has threatened mankind because many microorganisms are resistant. In particular, there continues to be a need for a direct cosmetic improvement to microorganisms that may adversely affect the body for the preservation of perishable products (such as cosmetics, medicines or foods) or for materials with antimicrobial properties for therapeutic treatment.
농약은 살균제, 살충제, 제초제, 생장 조절제 등으로 크게 나눌 수 있는데 바이러스나 미생물에 의한 작물 피해의 경우 살균제를 사용하여 방제한다. 농업 분야에서 값싸고 강력한 인공 합성된 항균물질들이 과도하게 사용됨으로써 우리 식탁을 위협하게 되었다. 인체에 직접 사용하는 생활용품에도 다양한 항균물질들이 사용되고 있으며 대부분 값이 싼 화학성분들이 사용되고 있다. 불행하게도 이렇게 사용되고 있는 항균물질들 대부분은 장기간 사용 시 인체에 해로울 수 있음이 과학적으로 밝혀지고 있다.Pesticides can be broadly divided into bactericides, insecticides, herbicides, and growth regulators. In the case of damage to crops caused by viruses or microorganisms, the use of fungicides is used. In the field of agriculture, cheap and powerful synthetic synthetic antimicrobials have become overuse, threatening our table. Various antimicrobial substances are also used in household products that are directly used in the human body, and most cheap chemical substances are used. Unfortunately, it has been scientifically proven that most of the antimicrobials used in this way can be harmful to humans for long periods of use.
우리 생활주변에서 널리 이용되는 식품, 의약품, 생활용품, 화장품 등의 많은 제품에는 내부물성의 변화를 방지하고, 일정기간 동안의 보존을 위해서 인체 사용이 허가된 항균물질인 방부제가 첨가되어 있다. 특히, 화장품은 손으로 떠서 사용하거나 인체와의 접촉이 잦은 제품의 특성상 외부로부터 미생물의 유입이 가능하고 이러한 미생물에 의하여 제품의 품질이 변할 수 있다. 특히, 눈가에 사용하는 제품의 오염은 눈병을 유발할 수 있는 위험성이 있으며, 1920년대 미국에서는 미생물에 의해 오염된 마스카라를 사용한 소비자가 실명한 사례가 있었다. 이에 따라, 미생물에 의한 상기 제품들의 오염을 방지하여 소비자의 안전을 확보하고 제품의 품질을 보존하는 기술이 꾸준히 개발되어 왔다.
Many products such as foods, medicines, daily necessities and cosmetics widely used in our daily lives are added with preservatives, which are antimicrobial substances approved for human use, to prevent changes in internal properties and to preserve them for a certain period of time. In particular, cosmetics can be used by hand, or due to the nature of products that are frequently in contact with human body, microorganisms can flow in from the outside and the quality of products can be changed by these microorganisms. In particular, there is a risk that contamination of products used in the eye can cause eye diseases. In the 1920s, there was a case where consumers using mascara contaminated by microorganisms were blinded. Accordingly, techniques for securing the safety of consumers and preserving the quality of products have been continuously developed by preventing contamination of the products by microorganisms.
한편, 상기 방부제로서 사용되고 있는 물질로는 천연에서 산출된 물질도 있으나 거의 대부분 화학적으로 합성한 인공물질들이 이용되고 있다. 기존 방부제로서 가장 안전하며 생활용품, 화장품, 의약품에 범용적으로 사용되는 파라벤류의 방부제들조차 피부 알러지(Andrea Counti et al., Contact Dermatitis, 1997, 37;35-36)와 환경호르몬으로서의 가능성(Edwin et al., Toxicology and applied pharmacology, 1998, 153;12-19) 및 내성균 유발이라는 문제점을 가지고 있다.On the other hand, as a substance used as the preservative, there are some materials derived from natural materials, but most of them are chemically synthesized artificial materials. Even preservatives of parabens, which are most safe as conventional preservatives and commonly used in household products, cosmetics, and medicines, have been shown to be effective against skin allergies (Andrea Counti et al., Contact Dermatitis, 1997, 37; 35-36) Edwin et al., Toxicology and applied pharmacology, 1998, 153, 12-19) and resistance to inducing resistant bacteria.
방부제로 사용되고 있는 천연활성 물질들의 경우 대부분 색취, 안정성 저하, 좁은 항균스펙트럼, 제형상 문제 등으로 인해 상용화되지 못하고 있으며, 편백 추출물인 히노키티올(hinokitiol)과 목련추출물인 마그놀롤(magnolol), 자몽추출물인 DF-100등 극히 일부만 상용화되고 있는 실정이다. 따라서, 기존 합성 화학 항균물질을 대체할 수 있는 천연 유래 항균 물질의 필요성이 극대화되고 있다. 특히, 항균제의 가장 큰 단점인 부작용을 줄이고 동시에 폭넓은 항균 스펙트럼, 제형상 안정성 등을 보유한 천연 항균 물질의 개발이 필요하다.
Most of the natural active substances used as preservatives are not commercialized because of color, stability, narrow antibacterial spectrum, shape problems, etc., and the hinokitiol, hinokitiol, Magnolol extract, grapefruit extract Such as DF-100, are commercially available. Therefore, the need for a naturally occurring antimicrobial substance capable of replacing the existing synthetic chemical antimicrobial substance is maximized. In particular, it is necessary to develop a natural antimicrobial substance having a wide range of antimicrobial spectrum and shape stability while reducing side effects, which are the biggest disadvantages of the antimicrobial agent.
이러한 배경하에, 본 발명자들은 기존 사용중인 항균물질들과의 혼합 사용으로 전체적인 피부 자극을 유발할 수 있는 성분의 절대량을 감소시키기 위하여 예의 노력한 결과, 옥틸 갈레이트를 사용하여 항균력 상승효과를 발휘하는 조합을 개발하게 되었다.
Under these circumstances, the present inventors have made intensive efforts to reduce the absolute amount of components that can induce overall skin irritation by mixing with antimicrobial substances that are currently in use, and as a result, they have found that a combination of using octyl gallate .
본 발명의 하나의 목적은 옥틸 갈레이트를 포함하는 화장료 조성물을 제공하는 것이다. One object of the present invention is to provide a cosmetic composition comprising octyl gallate.
본 발명의 다른 목적은 옥틸 갈레이트를 포함하는 의약외품 조성물을 제공하는 것이다.It is another object of the present invention to provide a quasi-drug composition comprising octyl gallate.
본 발명의 또 다른 목적은 옥틸 갈레이트를 포함하는 약학적 조성물을 제공하는 것이다.It is another object of the present invention to provide a pharmaceutical composition comprising octyl gallate.
본 발명의 또 다른 목적은 옥틸 갈레이트를 포함하는 항균 조성물을 제공하는 것이다.It is another object of the present invention to provide an antimicrobial composition comprising octyl gallate.
본 발명의 또 다른 목적은 옥틸 갈레이트를 포함하는 방부제 조성물을 제공하는 것이다.
It is another object of the present invention to provide a preservative composition comprising octyl gallate.
상기 목적을 달성하기 위한 하나의 양태로서, 본 발명은 옥틸 갈레이트(Octyl gallate)의 상승작용 목표 혼합물을 포함하는 조성물을 제공한다. 특히, 본 발명에서 상기 조성물은 옥틸 갈레이트 및 보존제 혼합물을 유효성분으로 포함하는 조성물로서, 상기 보존제는 1,2-알칸 다이올(1,2-alkane diol)인 것일 수 있다. 즉, 옥틸 갈레이트 및 1,2-알칸 다이올의 혼합물을 유효성분으로 포함하는 조성물일 수 있다.
In one aspect, the present invention provides a composition comprising a synergistic target mixture of octyl gallate. In particular, the composition of the present invention is a composition comprising octyl gallate and a preservative mixture as an active ingredient, wherein the preservative may be a 1,2-alkane diol. That is, it may be a composition comprising a mixture of octyl gallate and a 1,2-alkanediol as an active ingredient.
본 발명의 옥틸 갈레이트는 Octyl 3, 4, 5-trihydroxybenzoate의 IUPAC 이름, C15H22O5의 화학식과 282.33의 분자량을 갖는 물질일 수 있으며, 화학합성 방법 또는 효소를 이용한 방법으로 생산된 것일 수 있으나 이에 제한되지 않는다.The octyl gallate of the present invention may be a substance having an IUPAC name of Octyl 3, 4, 5-trihydroxybenzoate, a chemical formula of C 15 H 22 O 5 and a molecular weight of 282.33, and may be produced by a chemical synthesis method or an enzyme But is not limited thereto.
본 발명의 옥틸 갈레이트는 조성물의 총 중량에 대해 0.001 내지 50 %(w/v), 바람직하게는 0.01 내지 50 %(w/v), 보다 바람직하게는 0.1 내지 30%(w/v) 포함될 수 있다. 본 발명의 옥틸 갈레이트는 보존제와 함께 사용 시 상승작용을 일으키는 것일 수 있다.The octyl gallate of the present invention is contained in an amount of 0.001 to 50% (w / v), preferably 0.01 to 50% (w / v), more preferably 0.1 to 30% (w / v) . The octyl gallate of the present invention may be synergistic when used with a preservative.
본 발명의 용어 "상승작용 목표 혼합물"은 옥틸 갈레이트를 포함하며 옥틸 갈레이트와 혼합하여 사용될 때 항균 효과 면에서 각각을 단독으로 사용할 때보다 상승 효과(Synergic effect)를 갖는 모든 물질을 의미한다.The term " synergistic target mixture " of the present invention refers to all materials which contain octyl gallate and which, when used in admixture with octyl gallate, have a synergic effect than when each is used alone in terms of antimicrobial activity.
본 발명에서 상기 옥틸 갈레이트 및 보존제 혼합물에 포함되는 보존제는 옥틸 갈레이트와 혼합 사용 시 상승효과를 갖는 보존제를 제한없이 포함할 수 있으나, 특히 1,2-알칸 다이올일 수 있다. 예를 들어, 상기 1,2-알칸 다이올은 1,2-프로판다이올, 1,2-펜탄다이올, 1,2-헥산다이올, 1,2- 옥탄다이올 및 1,2-데케인다이올로 이루어진 군에서 선택된 하나 이상의 것일 수 있으나, 이에 제한되지 않는다.In the present invention, the preservative contained in the octyl gallate and the preservative mixture may include, without limitation, preservatives having synergistic effect when mixed with octyl gallate, but 1,2-alkanediol may be particularly used. For example, the 1,2-alkanediols can be selected from 1,2-propanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2- But are not limited thereto.
본 발명에 따른 옥틸 갈레이트와 보존제 혼합물이 유기물질의 보존을 위한 유효성분으로 사용되는 경우에는, 하나 이상의 추가 보존제를 추가하여 더욱 월등한 보존성(항균력)을 가질 수 있다. 바람직하게는 상기 추가 보존제는 추가 보존제를 추가로 포함하여 보존성이 단독 포함한 경우보다 상승적으로(synergic) 증가된 조성물로서, 상기 추가 보존제는 벤조산, 그 에스터 및 염, 프로피온산 및 그 염, 살리실산 및 그 염, 2,4-헥산산(소르빈산) 및 그 염, 포름알데히드 및 파라포름알데히드, 2-히드록시비페닐 에테르 및 그 염, 2-아연 술피드피리딘-N-옥시드, 무기 술파이트 및 비술파이트, 요오드 산 나트륨, 클로로브타노람, 4-에틸수은-(II)5-아미노-1, 3-비스(2-히드록시) 벤조산, 그 염 및 에스터, 데하이드로아세트산(dehydratcetic acid), 포름산, 1,6-비스(4-아미디노-2-브로모페녹시)-n-헥산 및 그 염, 에틸수은-(II)-티오 살리실산의 나트륨염, 페닐 수은 및 그 염, 10-운데실렌 산 및 그 염, 5-아미노-1,3-비스(2-에틸헥실)-5-메틸-헥사히드로 피리미딘, 5-브로모-5-니트로 1,3-다이옥산, 2-브로모-2-니트로-1,3-프로판다이올, 2,4-디클로로벤질알코올, N-(4-클로로페닐)-N'-(3,4-디클로로페닐)-요소, 4-클로로-m-크레졸, 2,4,4'-트리클로로-2'-히드록시-디페닐에테르, 4-클로로-3,5-디메틸 페놀, 1,1'-메틸렌-비스(3-(1-히드록시메틸-2,4-디옥시이미다졸리딘-5-일)요소)폴리-(헥사메틸렌지그아니드) 염산, 2-페녹시 에탄올, 헥사메틸렌테트라민, 1-(3-클로로 알릴)-3,5,7-트리아자-1-아조니아-아다만탄-염화물, 1(4-클로로 페녹시)-1(1 H-이미다졸-1-일)-3,3-디메틸-2-부타논, 1,3-비스-(히드록시-메틸)-5,5-디메틸-2,4-이미다졸리딘디온, 벤질알코올, 오크트피록스, 1,2-디브로모2,4-디시아노부탄, 2,2'-메틸렌-비스(6-브로모-4-클로로-페놀), 브로모-클로로펜, 염화 마그네슘 및 질산 마그네슘과의 5-클로로-2-메틸-3(2 H)-이소티아졸리논 및 2-메틸-3(2 H) 이소티아졸리논의 혼합물, 2-벤질-4-클로로페놀, 2-클로로아세트아미드, 클로로헥시딘, 클로로헥시딘 아세테이트, 클로로헥시딘 글루코네이트, 클로로헥시딘 염산, 1-페녹시-프로판-2-올, N-알킬(C12-C22) 트리메틸-암모늄 브로마이드 및 염화물, 4,4-디메틸-1,3-옥사졸리딘, N-히드록시메틸-N-(1,3-지(히드록시메틸)-2,5-디옥소이미다졸리딘-4-일)-N'-히드록시-메틸요소, 1,6-비스(4-아미디노 페녹시)-n-헥산 및 그 염, 글루타르알데하이드5-에틸-1-아자3,7-디옥사비사이클로(3.3.0) 옥탄, 3-(4-크롤 페녹시)-1,2-프로판다이올, 히아민(hyamine), 알킬-(C8-C18)-디메틸-벤질-암모늄-염화물, 알킬-(C8-C18)-디메틸-벤질 암모늄 브로마이드, 알킬-(C8-C18)-디메틸-벤질 암모늄 사카리네이트, 벤질헤미호르말, 3-요우드2-프로피닐-부틸카르바메이트, 및 나트륨 히드록시메틸 아미노 아세테이트로 이루어진 군에서 선택되는 하나 이상일 수 있으며, 특히 1,2-디브로모 2,4-디시아노부탄일 수 있다.When the mixture of octyl gallate and preservative according to the present invention is used as an active ingredient for the preservation of organic substances, it is possible to have a more excellent preservative (antibacterial activity) by adding one or more additional preservatives. Preferably, the additional preservative is a synergistically increased composition, wherein the preservative further comprises an additional preservative, wherein the additional preservative is selected from the group consisting of benzoic acid, its esters and salts, propionic acid and salts thereof, salicylic acid and salts thereof , 2,4-hexanoic acid (sorbic acid) and salts thereof, formaldehyde and paraformaldehyde, 2-hydroxybiphenyl ether and salts thereof, 2-zinc sulfide pyridine-N-oxide, (II) 5-amino-1,3-bis (2-hydroxy) benzoic acid, salts and esters thereof, dehydratcetic acid, formic acid, Hexahydrophthalic acid, 1,6-bis (4-amidino-2-bromophenoxy) -n-hexane and its salts, sodium salt of ethyl mercury- (II) thiosalicylic acid, phenyl mercury and salts thereof, Amino-1,3-bis (2-ethylhexyl) -5-methyl-hexahydropyrimidine, 5-bromo-5- 2-nitro-1,3-propanediol, 2,4-dichlorobenzyl alcohol, N- (4-chlorophenyl) -N '- (3,4- Chloro-m-cresol, 2,4,4'-trichloro-2'-hydroxy-diphenyl ether, 4-chloro-3,5-dimethylphenol, 1,1'-methylene -Bis (3- (1-hydroxymethyl-2,4-dioxiimidazolidin-5-yl) urea) Poly- (hexamethylene ziguanide) hydrochloric acid, 2-phenoxyethanol, hexamethylenetetramine , 1- (3-chloroallyl) -3,5,7-triaza-1-azonia-adamantane-chloride, l- (4-chlorophenoxy) ) -3,3-dimethyl-2-butanone, 1,3-bis- (hydroxy-methyl) -5,5-dimethyl-2,4-imidazolidinedione, benzyl alcohol, , 2-dibromo 2,4-dicyanobutane, 2,2'-methylene-bis (6-bromo-4-chloro-phenol), bromo-chlorophen, magnesium chloride, Chloro-2-methyl-3 (2 H) -isothiazolinone and 2-methyl-3 (2 H) 2-chloro-4-chlorophenol, 2-chloroacetamide, chlorohexidine, chlorohexidineacetate, chlorohexidine gluconate, chlorohexidine hydrochloride, 1-phenoxy- (C12-C22) trimethyl-ammonium bromide and chloride, 4,4-dimethyl-1,3-oxazolidine, N-hydroxymethyl- Hydroxymethyl) -2,5-dioxoimidazolidin-4-yl) -N'-hydroxy-methyl urea, 1,6-bis (4-amidinophenoxy) , Glutaraldehyde 5-ethyl-1-aza 3,7-dioxabicyclo (3.3.0) octane, 3- (4-chlorophenoxy) -1,2-propanediol, hyamine, Alkyl- (C8-C18) -dimethyl-benzyl-ammonium chloride, alkyl- (C8-C18) -dimethyl- benzylammonium bromide, alkyl- , 3-yordo-2-propynyl-butyl carbamate, and sodium hydroxymethyl aminoacetate It may be one or more selected from the group consisting of, and may be especially 1,2-dibromo-2,4-dicyano-butane.
본 발명의 구체적인 일 실시예에서는 옥틸 갈레이트 및 보존제(1,2-헥산다이올) 혼합물의 경우 각각 단독으로 사용하였을 때보다 항균 활성 상승지수(SI; Synergy indes)가 0.11인 것을 확인하여 본 발명의 혼합물의 항균 활성이 상승적으로 증가하는 것을 확인하였다(실시예 1, 표 2 및 표 7).In a specific example of the present invention, it was confirmed that the mixture of octyl gallate and preservative (1,2-hexanediol) had an antimicrobial activity increase index (SI) of 0.11, Was synergistically increased (Example 1, Table 2 and Table 7).
또한, 본 발명의 구체적인 일 실시예에서는 상기 옥틸 갈레이트 및 보존제(1,2-헥산다이올) 혼합물에 추가 보존제(Euxyl K400; 1,2-디브로모 2,4-디시아노부탄)을 추가한 조합 혼합물의 경우 각각 사용하였을 때보다 항균 활성 상승지수(SI)가 0.066인 것을 확인하여, 본 발명의 조합 혼합물의 항균 활성이 상승적으로 증가하는 것을 확인하였다(실시예 3, 표 9 및 표 10).In a specific embodiment of the present invention, an additional preservative (Euxyl K400; 1,2-dibromo 2,4-dicyanobutane) is added to the octyl gallate and the preservative (1,2-hexanediol) It was confirmed that the antimicrobial activity of the combination mixture of the present invention was increased synergistically (Example 3, Table 9, and Table 10 ).
즉, 본 발명에 따른 옥틸 갈레이트 및 보존제의 혼합물(a)의 장점과 이에 적어도 1종 이상의 추가 보존제(b)를 추가한 조합 혼합물의 장점은 실시예 1(옥틸 갈레이트와 보존제의 상승 효과) 및 실시예 3(옥틸 갈레이트/보존제 혼합물과 추가 보존제의 상승 효과)에 근거해 보다 상세하게 설명되었다.
That is, the advantages of the mixture (a) of octyl gallate and preservative according to the invention and the combined mixture with at least one additional preservative (b) added are the same as those of Example 1 (synergistic effect of octyl gallate and preservative) And Example 3 (synergistic effect of octyl gallate / preservative mixture and additional preservative).
상기 본 발명의 조성물은 옥틸 갈레이트와 보존제의 함유를 통하여 보존성이 더욱 상승되는 효과를 가짐으로써, 화장료 조성물, 의약외품 조성물, 약학적 조성물, 항균 조성물 또는 방부제 조성물 등의 다양한 분야에서 널리 사용될 수 있다.
The composition of the present invention can be widely used in various fields such as a cosmetic composition, a quasi-drug composition, a pharmaceutical composition, an antimicrobial composition or an antiseptic composition since it has an effect of increasing preservability by containing octyl gallate and a preservative.
본 발명의 조성물은 바람직하게는 세균, 진균 또는 효모에 대해 항균 활성을 가질 수 있으며, 더욱 바람직하게는 브레비박테륨 에피더미스, 코리네박테리움 키세로시스, 스파필로코커스 에피더미스, 프로피오니박테리움 아크네스, 트리코피톤 멘타그로피테스 및 에피데르모피톤 후로코슴에 대하여 옥틸 갈레이트 또는 보존제 단독으로 사용하였을 때보다 증가된 항균 활성을 가지는 조성물일 수 있다. 더욱 더 바람직하게는 브레비박테륨 에피더미스 ATCC 35514, 코리네박테리움 키세로시스 ACCC 771, 스파필로코커스 에피더미스 ATCC 12228, 프로피오니박테리움 아크네스 ATCC11829, 트리코피톤 멘타그로피테스 CBS 26379 및 에피데르모피톤 후로코슴 CBS 55384에 옥틸 갈레이트 또는 보존제 단독으로 사용하였을 때보다 증가된 항균 활성을 가지는 조성물일 수 있다.
The composition of the present invention may preferably have an antibacterial activity against a bacterium, fungus or yeast. More preferably, the composition of the present invention may further comprise an antibacterial agent selected from the group consisting of Brevibacterium epidermis, Corynebacterium kiocellis, Spaulicococus epidermis, It may be a composition having increased antimicrobial activity compared to octyl gallate or preservative alone when used against bacterium acnes, tricophyton mentagrophytes and epidermophyton frondosa. Even more preferably, Brevibacterium epidermis ATCC 35514, Corynebacterium kirilicis ACCC 771, Spiropylococus epidermis ATCC 12228, Propionibacterium acnes ATCC 11829, Tricophyton mentagrophytes CBS 26379 and It may be a composition having an antimicrobial activity that is increased than when octyl gallate or preservative alone is used in Epidermophyton fulocochle CBS 55384.
본 발명에서 용어, "항균"은 균에 저항하는 능력을 의미하며, 세균이나 곰팡이, 효도 등과 같은 미생물의 작용으로부터 방어하기 위해 이루어지는 모든 기작을 의미한다. In the present invention, the term "antibacterial" means the ability to resist bacteria and means all mechanisms that are carried out to defend against the action of microorganisms such as bacteria, fungi,
본 발명에서 용어, "세균"은 박테리아에 속하는 생물로서, 생명체들 중에 가장 많이 번성한 종으로 대부분 병원성 균이며 원핵생물의 특징을 그대로 가지고 있으나, 핵막이나 미토콘드리아, 엽록체와 같은 구조는 가지고 있지 않다. 크기는 0.5 μm 부터 0.5 mm 까지 다양하다. 상기 세균에는 예를 들어, 브레비박테륨 에피더미스, 코리네박테리움 키세로시스, 스파필로코커스 에피더미스, 프로피오니박테리움 아크네스, 트리코피톤 멘타그로피테스 및 에피데르모피톤 후로코슴이 포함될 수 있으며, 특히 브레비박테륨 에피더미스 ATCC 35514, 코리네박테리움 키세로시스 ACCC 771, 스파필로코커스 에피더미스 ATCC 12228, 프로피오니박테리움 아크네스 ATCC11829, 트리코피톤 멘타그로피테스 CBS 26379 및 에피데르모피톤 후로코슴 CBS 55384가 포함될 수 있다. In the present invention, the term "bacterium" is a bacterium belonging to bacteria. It is the most prolific species among living organisms, and most of them are pathogenic bacteria, but they do not have nucleus, mitochondria and chloroplast. Sizes range from 0.5 μm to 0.5 mm. The bacteria include, for example, Brevibacterium epidermis, Corynebacterium kerchisis, Spa pilococce epidermis, Propionibacterium acnes, Tricophyton mentagrophytes and Epidermophyton furocostae Such as Brevibacterium epidermis ATCC 35514, Corynebacterium kioclissis ACCC 771, Spiropylococus epidermis ATCC 12228, Propionibacterium acnes ATCC 11829, Tricophyton mentagrophytes CBS 26379 And Epidermophytone fulocom CBS 55384 may be included.
본 발명에서 용어, "진균"은 곰팡이, 효모, 버섯을 포함한 72, 000종 이상의 균종으로 구성되는 미생물군을 총칭하며, 핵막이 있는 진핵생물에 속하고, 미토콘드리아, 소포체 등의 세포 소기관이 발달해 있으며, 키틴, 글루칸 등으로 구성된 세포벽이 있다. 대부분은 세포성인 균사를 형성하여 신장, 발육하고 유성생식 및 무성생식을 하는 것이 특징이다. 번식체로 포자를 형성하지만 일부 균종은 단세포성 증식을 한다. 주로 부생균으로서 자연계의 유기분해에 관여하지만, 일부는 동식물에 기생 또는 공생한다. 상기 진균에는 예를 들어, 캔디다 알비칸스(Candida albicans) 및 아스퍼질러스 나이거(Aspergillus niger)이 포함된다. The term "fungus" in the present invention refers to a group of microorganisms consisting of more than 72,000 species including fungi, yeast and mushroom. It belongs to a nuclear eukaryote, and mitochondria and endoplasmic reticulum And there are cell walls composed of chitin, glucan, and the like. Most of them are characterized by the formation of cell-grown mycelium to elongate, develop, sexual reproduction and asexual reproduction. Spores are formed in the form of reproductive sperm but some of the species are unicellular. It is mainly a negative bacterium, but it is involved in the organic decomposition of nature, but some parasitism or symbiosis with plants and animals. Such fungi include, for example, Candida albicans and Aspergillus niger .
본 발명에서 용어, "효모"는 곰팡이, 버섯 무리이지만 균사가 없고, 광합성능이나 운동능도 가지지 않는 단세포 생물을 총칭하며, 가장 간단한 형태의 진핵생물로 인간의 세포 주기와 비슷한 세포주기를 가지는 것으로 알려져 있다. 상기 효모에는 예를 들어, 사카로마이세스 속, 피치아 속, 캔디다 속이 포함된다.
The term "yeast" in the present invention refers to a single-celled organism that is a fungus or mushroom herb but has no mycelium, no photosynthetic ability or motility, and has the simplest form of eukaryotes having a cell cycle similar to a human cell cycle It is known. The yeast includes, for example, Saccharomyces spp., Pichia spp., Candida spp.
본 발명의 바람직한 구현예에 따르면, 본 발명에 따른 옥틸 갈레이트 및 보존제 혼합물을 유효성분으로 포함하는 조성물은 브레비박테륨 에피더미스 ATCC 35514, 코리네박테리움 키세로시스 ACCC 771, 스파필로코커스 에피더미스 ATCC 12228, 프로피오니박테리움 아크네스 ATCC11829, 트리코피톤 멘타그로피테스 CBS 26379 및 에피데르모피톤 후로코슴 CBS 55384를 대상으로 상승작용적인 항균 활성을 가진다.According to a preferred embodiment of the present invention, the composition comprising the octyl gallate and the preservative mixture according to the present invention as an active ingredient is selected from the group consisting of Brevibacterium epidermis ATCC 35514, Corynebacterium kirilicis ACCC 771, Dermis ATCC 12228, Propionibacterium acnes ATCC 11829, Tricophyton mentagrophytes CBS 26379 and Epidermophyton furochom CBS 55384.
본 발명에 따른 1,2-알칸 다이올의 상승작용 목표 혼합물이 주로 동물의 유기체(animal organisms) 혹은 그 중의 바람직하지 않은 미생물의 생장의 억제를 위해서 사용되는 경우에는, 항균 혹은 항진균활성 화합물과의 조합도 경우에 따라서는 유리할 수 있다. 이것에 관해서 적합한 활성화합물로는 큰 군의 통상의 항생물질이 가능하며, 그 중에서도 겨드랑 밑취, 족취 혹은 비듬에 대해서 사용될 수 있다. 특히 화장품에 관련하는 제품, 예를 들면 트리크로산, 크리바조르, 오크톡시글리세롤, 오크트피록스(1-히드록시-4-메틸-6-(2,4, 4-트리메틸펜틸)-2(1 H)-피리돈, 2-아미노 에탄올), 키토산, 파르네솔, 글리세롤 모노 라우레이트 혹은 상기 물질의 조합일 수 있다.Synergistic action of the 1,2-alkanediol according to the present invention When the target mixture is mainly used for inhibiting the growth of animal organisms or undesirable microorganisms therein, Combinations can also be advantageous depending on the case. Suitable active compounds for this are large groups of conventional antibiotics, which can be used, for example, for axillas, jaws or dandruff. Especially products related to cosmetics such as triclosan, cribasol, ocotoxyglycerol, orcpypox (1 -hydroxy-4-methyl-6- (2,4,4-trimethylpentyl) 1 H) -pyridone, 2-aminoethanol), chitosan, parnesol, glycerol monolaurate or a combination of the above materials.
또한, 1,2-알칸 다이올의 상승작용 목표 혼합물은 체취를 억제하기 위해서 발한 억제 활성화합물(제한제)과 조합하여 사용할 수 있다. 사용되는 발한 억제 활성화합물은 특히 알루미늄염, 예를 들면 염화알루미늄, 알루미늄 클로로 하이드레이트, 나이트 레이트, 설페이트, 아세테이트 등이다. 그러나, 추가로 아연, 마그네슘 및 지르코늄 화합물의 사용도 유리하다고 할 수 있다. 본질적으로는 알루미늄염과 다소 효과는 크지 않지만 적지만 알루미늄/지르코늄염 조합물이 화장품 및 피부과학적 제한제 중에서 효과를 증명했다. 이와 같이 피부에 보다 좋고 허용되지만 그만큼 유효가 아닌 일부 중화된 알루미늄 히드록시 염화물도 적합하다. 알루미늄염에 가세하고, 예를 들면 a) 땀샘의 표면 폐쇄증을 일으키는 포름알데히드, 글루타르알데하이드, 천연 및 합성 탄닌제(tanning agents) 및 삼염화초산과 같은 단백질-응결물질, b) 말초 신경 날줄을 차단하는 것으로써 땀샘의 교감신경 공급을 차단하는 국소마취제(그 중에서도, 예를 들면 리도카인, 프릴로카인 혹은 이러한 물질의 혼합물의 희석 용액), c) 땀 분비 감소에 가세하고, 더욱 악취의 흡수제로서 일하는 X, A 혹은 Y형의 제올라이트, 및 d) 다한, 병리학적으로 증가한 땀 분비의 증례에도 사용되고 그 작용이 땀 분비에 관여하는 전달물질의 아세틸콜린의 방출의 비가역적 차단에 근거하는 보툴리누스독소(박테리아의 클로스트리듐·보트리눔의 독소)와 같은 물질도 사용할 수도 있다.
In addition, the synergistic target mixture of 1,2-alkanediols can be used in combination with an anti-perspirant compound (inhibitor) to suppress body odor. The antiperspirant active compounds used are in particular aluminum salts, such as aluminum chloride, aluminum chlorohydrate, nitrate, sulfate, acetate and the like. However, the use of further zinc, magnesium and zirconium compounds is also advantageous. Although somewhat less effective than aluminum salts in essence, alumina / zirconium salt combinations have proven effective in cosmetic and dermatological limitations. Thus, some neutralized aluminum hydroxy chlorides that are better and acceptable for the skin, but not as effective, are also suitable. In addition to aluminum salts, for example: a) protein-coagulating substances such as formaldehyde, glutaraldehyde, natural and synthetic tanning agents and trichloroacetic acid which cause surface insult of the glands, b) (For example, lidocaine, prilocaine or a diluted solution of a mixture of these substances), which interrupts the supply of sympathetic nerves of the sweat glands by cessation of sweat secretion, X, A, or Y zeolites, and d) Botulinum toxin, which is also used in cases of pathologically increased sweat secretion and whose action is based on the irreversible blockade of the release of acetylcholine from the transmitter that is involved in sweat secretion Of Clostridium botulinum) can also be used.
본 발명에 따른 옥틸 갈레이트의 상승작용 목표 혼합물이 표면(예를 들면 인간 혹은 동물의 신체의)의 항균 처리에 사용되는 경우에는, (금속) 킬레이트와의 조합이 경우에 따라서는 유리할 수 있다. 특히, 바람직하게 사용할 수 있는 (금속) 킬레이트로는 α-히드록시 지방산, 파이틴산, 락토레린, α-하이드록시산, 예를 들면 특히, 시트르산, 유산 및 사과산, 및 후민산, 쓸개즙 산, 쓸개즙 추출물, 빌리루빈, 빌리버딘 혹은 EDTA, EGTA 및 이들의 유도체 등이 있을 수 있다.
Synergistic action of octyl gallate according to the present invention. When the target mixture is used for the antimicrobial treatment of the surface (for example of a human or animal body), the combination with (metal) chelate may be advantageous in some cases. Particularly preferred (metal) chelates that can be used include, but are not limited to,? -Hydroxy fatty acids, phytinic acid, lactoterein,? -Hydroxy acids such as citric acid, lactic acid and malic acid, Biliary extract, bilirubin, biliveridine or EDTA, EGTA and derivatives thereof.
본 발명의 옥틸 갈레이트 및 보존제(1,2-알칸 다이올)을 유효성분으로 함유하는 항균활성 효과를 갖는 각종 조성물은 예를 들면, 액상, 크림상, 페이스트상, 고체상 등 어떠한 제형으로도 응용될 수 있으며, 그 용도도 다양한 분야에 적용될 수 있다. 예를 들면 전신, 피부, 구강, 모발 등 인체관련 세정제 등 각종 화장료 조성물 등에 적용될 수 있다.Various compositions having an antimicrobial activity effect containing octyl gallate and a preservative (1,2-alkanediol) as an active ingredient of the present invention can be applied to any formulations such as liquid, cream, paste, And its use can be applied to various fields. And can be applied to various cosmetic compositions such as a body-related cleanser for body, skin, mouth, hair and the like.
또한, 본 발명에 따른 조성물에는 유효 성분으로서의 옥틸 갈레이트 및/또는 보존제 이외에 추가적으로 당업계에 공지된 항균활성을 가진 물질이 포함될 수 있다.
In addition to the octyl gallate and / or preservative as the active ingredient, the composition according to the present invention may further include a substance having antibacterial activity known in the art.
또 하나의 양태로서, 본 발명은 옥틸 갈레이트 및 보존제(1,2-알칸 다이올)을 유효 성분으로 함유하는 화장료 조성물을 제공한다. 특히, 항균 성분으로 옥틸 갈레이트 및 보존제(1,2-알칸 다이올)를 유효 성분으로 함유하는 화장료 조성물을 제공한다. In another aspect, the present invention provides a cosmetic composition comprising octyl gallate and a preservative (1,2-alkanediol) as an active ingredient. In particular, a cosmetic composition comprising octyl gallate and a preservative (1,2-alkanediol) as an antibacterial component is provided as an active ingredient.
화장료 조성물은 유효 성분으로서 옥틸 갈레이트 및 보존제 혼합물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함하며, 예를 들어 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제 및/또는 담체를 포함할 수 있다. The cosmetic composition contains, in addition to the octyl gallate and the preservative mixture as an active ingredient, the components conventionally used in cosmetic compositions, and may contain conventional additives such as, for example, antioxidants, stabilizers, solubilizers, vitamins, Carrier.
본 발명의 옥틸 갈레이트 및 보존제 혼합물을 화장료 첨가물로 사용할 경우, 상기 혼합물은 그대로 첨가되거나 다른 화장료 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분의 혼합량은 사용 목적 (예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다.When the octyl gallate and preservative mixture of the present invention is used as a cosmetic additive, the mixture may be added as it is or may be used together with other cosmetic ingredients, and may be suitably used according to conventional methods. The amount of the active ingredient to be mixed can be suitably determined according to the intended use (prevention, health or therapeutic treatment).
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 크림, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 포옴, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.The cosmetic composition of the present invention can be prepared into any of the formulations conventionally produced in the art and can be used as a solution, a suspension, an emulsion, a paste, a gel, a cream, a lotion, a powder, a soap, , Oil, powder foundation, emulsion foundation, wax foundation and spray, but is not limited thereto. More specifically, it can be manufactured in the form of a soft lotion, a nutritional lotion, a cream, a nutritional cream, a massage cream, an essence, an eye cream, a cleansing cream, a cleansing foam, a cleansing water, a pack, a spray or a powder.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, an animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier component .
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In the case of a spray, in particular, / Propane or dimethyl ether.
또한, 본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1, 3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a solution or an emulsion, a solvent, a solubilizing agent or an emulsifying agent is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, , 1, 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol, or fatty acid esters of sorbitan.
또한, 본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.In addition, when the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspension such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.
또한, 본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is an interface-active agent-containing cleansing, the carrier component may include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, Fatty acid amide ether sulfate, alkylamidobetaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, or ethoxylated glycerol fatty acid ester.
본 발명의 화장료 조성물에서, 옥틸 갈레이트 및 보존제 혼합물의 양은 전체 조성물에 대하여 0.001 내지 50 %(w/v), 바람직하게는 0.01 내지 50 %(w/v), 보다 바람직하게는 0.1 내지 30 %(w/v)로 포함될 수 있다.
In the cosmetic composition of the present invention, the amount of the octyl gallate and the preservative mixture is 0.001 to 50% (w / v), preferably 0.01 to 50% (w / v), more preferably 0.1 to 30% (w / v).
본 발명에 따른 옥틸 갈레이트의 상승작용 목표 혼합물을 미용적 및/또는 화장료 조성물로 사용할 경우, 화장품 및 피부과학적 제품에 포함되어 통상의 방법으로 피부 및/혹은 모발에 적량 적용될 수 있다. 이에 관하여 본 발명에 따른 혼합물을 함유하는 자외선 차단제의 용도를 갖는 화장품 및 화장료 조성물은 구체적인 장점을 가진다. 구체적으로 상기 조성물은 적어도 1종의 UVB 필터 및/혹은 적어도 1종의 무기 색소를 함유한다. 예를 들면, 자외선 차단제 조성물에 통상 사용되는 여러 가지 형태일 수 있다. 따라서 그것들은 예를 들면, 용액, water-in-oil(W/O) 형 혹은 oil-in-water(O/W) 형의 에멀젼 또는 예를 들면 water-in-oil-in- water(W/O/W) 형의 다중 에멀젼, 겔제, 히드로분산물, 고체 스틱 또는 에어졸 일 수 있다.Synergistic action of octyl gallate according to the present invention When the target mixture is used as a cosmetic and / or cosmetic composition, it may be contained in cosmetics and dermatological products and applied in an appropriate amount to skin and / or hair in a usual manner. In this respect, the cosmetic and cosmetic compositions having the use of the ultraviolet screening agent containing the mixture according to the present invention have specific advantages. Specifically, the composition contains at least one UVB filter and / or at least one inorganic dye. For example, it can be of various forms commonly used in sunscreen compositions. They can therefore be used, for example, as emulsions in the form of solutions, water-in-oil (W / O) or oil-in-water (O / W) O / W) multiple emulsions, gels, hydrodispersions, solid sticks or aerosols.
상기와 같이, 옥틸 갈레이트와 상승작용 목표 혼합물을 함유하는 조성물은 UV광선을 흡수하는 물질과 유리하게 조합하여 자외선에 대해서 모발 및/혹은 피부를 보호하는 기능이 증가되는 것이 가능하다. 상기 화장품 조성물에서 옥틸 갈레이트와 상승작용 목표 혼합물의 조성은 조성물의 총중량에 근거해 0.01%(w/w)~40%(w/w), 바람직하게는 0.1%(w/w)~10%(w/w), 특히 1.0~5.0%(w/w)일 수 있다.As described above, a composition containing octyl gallate and a synergistic target mixture can be advantageously combined with a material that absorbs UV light to increase the function of protecting hair and / or skin against ultraviolet light. The composition of octyl gallate and the synergistic target mixture in the cosmetic composition may be from 0.01% (w / w) to 40% (w / w), preferably from 0.1% (w / w) to 10% (w / w), in particular 1.0 to 5.0% (w / w).
본 발명에 따른 조성물이 UVB 필터 물질을 함유하는 경우에는 유용성 혹은 수용성일 수 있다. 유리한 유용성 UVB 필터는 예를 들면, 3-벤질리덴캄퍼 유도체, 바람직하게는 3-(4-메틸벤질리덴) 강심제-, 3-벤질리덴캄퍼, 4-아미노벤젠산 유도체, 바람직하게는 4-(디메틸아미노) 벤조산2-에틸헥실, 4-(디메틸아미노) 벤조산 아밀, 계피산의 에스터, 바람직하게는, 4-메톡시 계피산2-에틸헥실, 4-메톡시 계피산 이소 펜틸, 살리실산의 에스터, 바람직하게는 살리실산2-에틸헥실, 살리실산4-이소프로필 벤질, 살리실산 호모 멘틸, 벤조페논의 유도체, 바람직하게는 2-히드록시-4-메톡시벤조 페논, 2-히드록시-4-메톡시-4'-메틸벤조 페논, 2,2'-디히드록시-4-메톡시벤조 페논, 벤잘말론산의 에스터, 바람직하게는 4-메톡시벤자르마론산(2-에틸헥실), 2,4,6- When the composition according to the invention contains UVB filter material it may be useful or water-soluble. Advantageous utility UVB filters are, for example, 3-benzylidene camphor derivatives, preferably 3- (4-methylbenzylidene) cordierite, 3- benzylidene camphor, 4-aminobenzenic acid derivatives, 2-ethylhexyl benzoate, amyl 4- (dimethylamino) benzoate, ester of cinnamic acid, preferably 2-ethylhexyl 4-methoxy cinnamate, isopentyl 4-methoxy cinnamate, esters of salicylic acid, 2-ethylhexyl salicylate, 4-isopropylbenzyl salicylate, homomenthyl salicylate, benzophenone derivatives, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy- -Methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone, esters of benzalmalonic acid, preferably 4-methoxybenzalmaronic acid (2-ethylhexyl), 2,4,6 -
트리아니리노(p-칼보-2'-에틸-1'-헥실옥시)-1,3,5-트리아진이다. 유리한 수용성 UVB 필터는, 예를 들면 2-페닐 벤즈이미다졸-5-설폰산의 염, 염르로써 나트륨, 포타슘 혹은 트리에탄올암모늄염 및 설폰, 벤조페논의 설폰산 유도체, 바람직하게는 2-히드록시-4-메톡시벤조 페논-5-설폰산 및 그 염, 3-벤질리덴캄퍼의 설폰산 유도체, 예를들면 4-(2-옥소-3-보르니리덴메틸) 벤젠 설폰산, 2-메틸-5-(2-옥소-3-보르니리덴메틸) 설폰산 및 그 염, 1,4-지(2-옥소-10-설포-3-보르니리덴메틸)-벤젠 및 그 염(10-술파토 화합물, 예를 들면 나트륨, 포타슘 혹은 트리에탄올암모늄염) 혹은 벤젠-1,4-지(2-옥소-3-보르니리덴메틸10-설폰산일 수 있다.
Tri-anilino (p-carbo-2'-ethyl-1'-hexyloxy) -1,3,5-triazine. Advantageous water-soluble UVB filters are, for example, salts of 2-phenylbenzimidazole-5-sulfonic acid, salts of sodium, potassium or triethanolammonium salts and sulfone, benzophenone sulfonic acid derivatives, preferably 2-hydroxy- Methoxybenzophenone-5-sulfonic acid and salts thereof, sulfonic acid derivatives of 3-benzylidene camphor, for example 4- (2-oxo-3-boronidene methyl) benzenesulfonic acid, (2-oxo-10-sulfo-3-boronylidenemethyl) -benzene and salts thereof (10-sulfato Compounds such as sodium, potassium or triethanol ammonium salts) or benzene-1,4-di (2-oxo-3-boronidene methyl 10-sulfonic acid.
본 발명에 따른 옥틸 갈레이트의 상승작용 목표 혼합물은 이러한 조성물에 통상 사용되는 화장품 보조제, 따라서 예를 들면 산화방지제, 향유, 발포를 억제하는 물질, 착색제, 착색 작용을 가지는 색소, 증점제, 세정력 물질, 유화제, 가소화 물질, 가습 및/혹은 보습 물질, 지방, 기름, 왁스, 화장료 조성물의 그 외의 통상의 성분(예를 들면 알코올, 폴리올, 폴리머, 기포 안정제, 전해질, 유기 용매 혹은 실리콘 유도체)와 혼합하여 사용될 수 있다. The synergistic target mixture of octyl gallate according to the present invention is a cosmetic adjuvant commonly used in such a composition, and therefore, for example, antioxidants, perfume oils, foaming inhibitors, colorants, coloring pigments, thickeners, (For example, an alcohol, a polyol, a polymer, a foam stabilizer, an electrolyte, an organic solvent, or a silicone derivative) of an emulsifier, a plasticizer, a humidifying and / or moisturizing substance, a fat, Can be used.
피부의 국소의 예방 혹은 미용적 처치를 위한 옥틸 갈레이트의 상승 작용 목표 활성 혼합물을 함유하는 조성물이 고함량 처리된 물질은 유리하게 작용할 수 있다. 바람직한 일 양태로서, 조성물은 1종 혹은 복수의 동물 및/혹은 식물의 처치용 지방 및 기름, 예를 들면 올리브유, 해바라기유, 정제 대두유, 야자유, 참기름, 평지씨 기름, 아몬드유, 르치샤유, 달맞이꽃유, 코코넛유, 시아버터, 죠죠바유, 밀향경유, 우지, 수유 및 지방 및 혹은 경우에 따라서는 한층 더 가공 성분, 예를 들면 8 ~ 30 탄소 원자를 가지는 지방 알코올을 함유한다. 여기서 지방 알코올은 포화 혹은 불포화로 직쇄 혹은 분지 사슬일 수 있다. 예를 들면 데칸올, 데세놀, 오크 테너, 도데카놀, 드데세노르, 오타지에노르, 데카지에노르일 수 있다.
Synergistic action of octyl gallate for the prevention of topical or cosmetic treatment of the skin. A composition containing a high activity of the composition containing the target active mixture may be advantageous. In a preferred embodiment, the composition comprises one or more animal and / or plant treatment fats and oils such as olive oil, sunflower oil, refined soybean oil, palm oil, sesame oil, rapeseed oil, almond oil, Coconut oil, shea butter, jojoba oil, diesel oil, tallow, milk and fat and optionally further processing components, for example fatty alcohols having 8 to 30 carbon atoms. Here, fatty alcohols may be saturated or unsaturated, linear or branched. For example, decanol, decenol, oak tenor, dodecanol, dodecenor, otazienor, decazenor.
또한, 본 발명에 따른 옥틸 갈레티으의 상승작용 목표 혼합물과의 조합이 바람직하고 조합의 물질은 세라마이드, 여기서 세라마이드는 각질 층의 보수능을 분명하게 개선하는 N-아실 스핑고신(스핑고신의 지방산 아마이드) 혹은 이러한 지방의 합성 유사체(이른바 유사-세라마이드)이고; 인지질, 예를 들면 대두 레시틴, 알 레시틴 및 세팔린; 바셀린, 파라핀 및 실리콘오일, 후자는 특히 디알킬- 및 알킬 아릴-실록산, 예를 들면 다이메타이콘 및 메틸 페닐 폴리실록산 및 그러한 알콕실화 및 제4급화 유도체를 포함한다.
In addition, the combination of the octyl gallate according to the present invention with the synergistic target mixture is preferred, and the combination material is ceramide, wherein the ceramide is an N-acylsuphinosine Amides) or synthetic analogues of these fats (so-called pseudo-ceramides); Phospholipids such as soybean lecithin, alesitin and cephalin; Petrolatum, paraffin and silicone oil, the latter in particular dialkyl- and alkylaryl-siloxanes such as dimethicone and methylphenylpolysiloxane and such alkoxylated and quarternized derivatives.
동물 및/혹은 식물의 가수분해 단백질도 또한 유리하게 본 발명에 따른 옥틸 갈레이트의 상승작용 목표 혼합물에 첨가할 수 있다. 이것에 관하여, 특히 엘라스틴, 콜라겐, 케라틴, 유즙단백, 대두단백질, 오토 단백질, 완두단백질, 아몬드 단백질 및 밀 단백질 화분 혹은 대응하는 가수분해 단백질, 그러나 지방산과의 축합 생성물, 및 더욱 자세하게는 제4급화 가수분해 단백질이 유리하고, 여기서 식물의 가수분해 단백질의 사용이 바람직하다.
Hydrolyzed proteins of animals and / or plants may also be advantageously added to the synergistic target mixture of octyl gallate according to the invention. In this regard, it is also possible to use in particular, elastin, collagen, keratin, milk protein, soy protein, auto protein, pea protein, almond protein and wheat protein flower or corresponding hydrolyzed protein but with condensation products with fatty acids, Hydrolyzed proteins are advantageous, wherein the use of plant hydrolyzed proteins is preferred.
본 발명에 따른 옥틸 갈레이트의 상승작용 목표 혼합물을 함유하는 화장품 혹은 화장품 조성물이 물약 혹은 로션인 한, 사용되는 용매는 물 혹은 수용액; 지방유, 지방, 왁스 및 다른 천연 및 합성 지방 물질, 바람직하게는 저 탄소수를 가지는 알코올, 예를 들면 아이소프로판올, 프로필린글리콜 혹은 글리세롤과의 지방산 에스터, 또는 저탄소수를 가지는 알칸 산과도 같은 지방알코올의 에스터; 저탄소수를 가지는 알코올, 다이올 혹은 폴리올 및 그러한 에테르, 바람직하게는, 에탄올, 아이소프로판올, 프로필린글리콜, 글리세롤, 에틸렌글리콜, 에틸렌글리콜 에틸 혹은 모노부틸에테르, 프로필린글리콜 모노메틸, 에틸 혹은 모노부틸에테르, 다이에틸렌글리콜 모노메틸 혹은 에틸에테르 및 유사 제품일 수 있다. 특히 상기의 용매의 혼합물이 사용될 수 있다. Synergistic action of octyl gallate according to the present invention When the cosmetic or cosmetic composition containing the target mixture is a potion or lotion, the solvent used is water or an aqueous solution; Fatty alcohols such as fatty acids, fatty acids, fatty acids, fats, waxes and other natural and synthetic fatty substances, preferably alcohols having a low carbon number, such as isopropanol, propyleneglycol or glycerol, or alkanoic acids having low carbon numbers Ester; Alcohols, diols or polyols having a low carbon number and such ethers and preferably ethers such as ethanol, isopropanol, propyleneglycol, glycerol, ethylene glycol, ethylene glycol ethyl or monobutyl ether, propyleneglycol monomethyl, ethyl or monobutyl Ether, diethylene glycol monomethyl or ethyl ether, and the like. In particular, mixtures of the above solvents may be used.
본 발명에 따른 옥틸 갈레이트의 상승작용 목표 혼합물을 함유하는 화장료 조성물은 산화방지제를 함유할 수 있어 여기서 미용적 및/혹은 피부과학적 적용에 적절한 것도 거기에 통상의 모든 산화방지제를`사용할 수 있다. 산화방지제는 유리하게는, 매우 낮은 허용 용량에 있어서의, 아미노산(예를 들면 글리신, 히스티딘, 티로신) 및 그러한 유도체, 이미다졸(예를 들면 우로카닌 산) 및 그러한 유도체, D, L-카르노신, D-카르노신, L-카르노신 및 그러한 유도체(예를 들면 안세린)와 같은 펩타이드, 카로티노이드, 카로틴(예를 들면 α-카로틴, β-카로틴, 리코펜) 및 그러한 유도체, 리포산 및 그 유도체(예를 들면 다이하이드로리포산), 아우로치오글루코스, 프로필티오유라실 및 다른 티올(예를 들면 티오레독신, 글루타티온, 시스테인, 시스틴, 시스타민 및, 그러한 글리코실, N-아세틸, 메틸, 에틸, 프로필기, 아밀, 부틸 및 라우릴, 팔미토일, γ-리노레일, 콜레스테릴 및 글리세릴에스테르) 및 이들의 염, 티오디프로피온 산 디라우릴, 티오디프로피온 산 디스테아릴, 티오디프로피온 산 및 그 유도체(에스터, 에테르, 펩타이드, 지방, 뉴클레오티드, 뉴클레오시드 및 소금) 및 설폭시 이민 화합물(예를 들면 브티오닌·설폭시 이민, 호모시스테인·설폭시 이민, 브티오닌·설폰, 펜터, 헥사- 및 헵타-티오닌·설폭시 이민), 및 더욱, (금속) 킬레이트 형성 제(예를 들면 α-히드록시 지방산, 팔미틴 산, 파이틴산, 락토페린), α-하이드록시산(예를 들면 시트르산, 유산, 사과산), 후민산, 쓸개즙 산, 쓸개즙 추출 물건, 빌리루빈, 빌리버딘, EDTA, EGTA 및 그러한 유도체, 불포화 지방산 및 그러한 유도체(예를 들면 γ-리놀렌산, 리놀레산, 올레산), 엽산 및 그 유도체, 유비퀴논 및 유비키노르 및 그러한 유도체, 비타민 C 및 유도체(예를 들면, 팔미틴 산 아스콜빌, 인산 아스콜빌 Mg, 아세트산 아스콜빌), 토코페롤 및 그러한 유도체(예를 들면 아세트산 비타민 E), 비타민 A 및 그 유도체(팔미틴 산비타민 A) 및 더욱 벤조인 수지의 벤조산 코니페릴, 루틴 산 및 그 유도체, 펠라산 및 그 유도체, 부틸 히드록시 톨루엔, 부틸하이드록시아니솔, 노르디히드로 구아이악 산, 노르디히드로그아야레틴산, 히드록시 부티로페논, 요산 및 그 유도체, 만노스 및 그 유도체, 아연 및 그 유도체(예를 들면 ZnO, ZnSO4), 셀레늄 및 그 유도체(예를 들면 셀레늄·메티오닌), 스틸벤 및 그러한 유도체(예를 들면 산화 스틸벤, 트랜스-산화 스틸벤) 및 더욱, 상기의 유효 화합물의 유도체(염, 에스터, 에테르, 당, 뉴클레오티드, 뉴클레오시드, 펩타이드 및 지방)로 구성되는 군으로부터 선택될 수 있다.
The cosmetic composition containing the synergistic target mixture of octyl gallate according to the present invention may contain an antioxidant so that it can be used for cosmetic and / or dermatological applications as well as any conventional antioxidant. Antioxidants advantageously include amino acids (such as glycine, histidine, tyrosine) and derivatives thereof, imidazoles (such as uronic acid) and derivatives thereof, D, L-carnosine , Carotenoids (e.g., alpha -carotene, beta -carotene, lycopene) and derivatives thereof, lipoic acid and derivatives thereof (for example, peptides such as D-carnosine, L-carnosine and such derivatives Acetyl, methyl, ethyl, isopropyl, n-butyl, isobutyl, isopropyl, n-butyl, isobutyl, isobutyl, Amyl, butyl and lauryl, palmitoyl, gamma -linoleyl, cholesteryl and glyceryl esters) and their salts, thiadiopropionic acid dilauryl, thiodipropionic acid distearyl, thiodipropyl Acid and its derivatives (esters, ethers, peptides, fats, nucleotides, nucleosides and salts), and sulfoximine compounds (such as bithionine sulfoximine, homocysteine, sulfoximine, Hydroxycarboxylic acids (for example, urea, urea, urea, urea, urea, urea, urea, Such as citric acid, lactic acid, malic acid, fumaric acid, bile acids, bile extracts, bilirubin, viliverdine, EDTA, EGTA and such derivatives, unsaturated fatty acids and derivatives thereof (for example,? -Linolenic acid, linoleic acid, oleic acid) Folic acid and derivatives thereof, ubiquinone and ubiquinone and derivatives thereof, vitamin C and derivatives (for example, ascorbyl palmitate, ascorbyl phosphate Mg, ascorbyl acetate), tocopherol and derivatives thereof Acetic acid (Vitamin E), vitamin A and its derivatives (palmitic acid vitamin A), and furthermore benzoic acid coniferyl benzoate, rutinic acid and its derivatives, pelacic acid and its derivatives, butylhydroxytoluene, butylhydroxyanisole, (For example, ZnO, ZnSO 4 ), selenium and derivatives thereof (for example, sodium dodecylbenzenesulfonate, sodium dihydrogenphosphate, Ester, ether, sugar, nucleotide, nucleoside, peptide (for example, selenium-methionine), stilbene and such derivatives (for example stilbene oxide, trans-stilbene oxide) And fat).
본 발명에 따른 옥틸 갈레이트의 상승작용 목표 혼합물을 함유하는 화장료 조성물은 비타민 및 비타민 전구체를 함유할 수 있어 화장품 및/혹은 피부과학적 적용에 적절하게 사용될 수 있고 거기에 통상의 모든 비타민 및 비타민 전구체를 사용할 수 있다. 특히 토코페롤, 비타민 A, 니코틴산 및 나이아신아마이드, B 복합체의 비타민, 특히 바이오틴, 및 비타민 C, 판트테니르알코올 및 그 유도체, 특히 판트테니르알코올의 에스터 및 에테르, 및 양이온의 판트테니르알코올의 유도체, 예를 들면 판트테니르알코올트리아세테이트, 판트테니르알코올모노에틸에이텔 및 아세테이트 및 양이온의 판트테니르알코올 유도체와 같은 비타민 및 비타민 전구체가 함유될 수 있다.
The cosmetic composition containing the synergistic target mixture of octyl gallate according to the present invention can contain vitamins and vitamin precursors and can be used suitably for cosmetic and / or dermatological applications and contains all the usual vitamins and vitamin precursors Can be used. Especially vitamins of tocopherol, vitamin A, nicotinic acid and niacinamide, B complex, especially biotin, and vitamin C, pantothenic alcohol and its derivatives, especially the esters and ethers of pantothenic alcohol, and derivatives of pantothenic alcohol of cations , Vitamin and vitamin precursors such as, for example, pantothenic alcohol triacetate, pantothenic alcohol monoethyl acetal and acetate, and pantothenic alcohol derivatives of cations.
본 발명에 따른 옥틸 갈레이트 및 상승작용 목표 혼합물을 함유하는 화장료 조성물은 항염증작용 화합물 및/또는 발적 및/혹은 가려움을 경감하는 활성화 합물을 함유할 수 있다. 이것에 관한, 화장품 및/혹은 피부 과학적 적용에 적절한 것도 있고 그것들에 통상의, 모든 항염증 작용 화합물 및 발적 및/혹은 가려움을 경감하는 활성화합물을 사용할 수 있다. 사용되는 항염증작용 화합물 및 발적 및/혹은 가려움을 경감하는 활성화합물은 유리하게는, 코르티코스테로이드 형태의 스테로이드성 항염증 물질, 예를 들면 하이드로코티손, 덱사메타손, 덱사메타손 포스페이트, 메틸프레드니솔론 혹은 코르티손이어, 여기서 한층 더 스테로이드 성 항염제를 추가하는 것으로써 리스트를 확대할 수 있다. 비스테로이드성항염증제도 또한 사용할 수 있다. 옥시캠(예를 들면 피록시캄 혹은 테노키시캄), 살리실레이트(예를 들면 아스피린, 지사르시드(Disalcid), 솔 퓨린 혹은 펜드서르), 아세트산 유도체(예를 들면 디클로페낙, 펜크로페낙크, 인도메타신, 술린닥, 톨메틴 혹은 크리다낙크), 페나메이트(예를 들면 메페나믹크, 메크로페나믹크, 후르페나믹크 혹은 니후르믹크), 프로피온산 유도체(예를 들면 이브로펜, 나프록센, 베녹사프로펜) 또는 피라졸(예를 들면 페닐부타존, 옥시페닐브타존, 페브라강 혹은 아자프로파존)을 예로서 여기에 올릴 수 있다. 혹은 천연의 항 염증 물질 및 발적 및/혹은 가려움을 경감하는 물질을 사용할 수 있다. 식물 추출물, 특히 현저하게 활성인 식물 추출물 및 식물 추출물로부터 단리된 고도의 순수한 활성 물질을 사용할 수 있다. 카밀레, 알로에, 코미호라종(Commiphora species), Rubia 종, 버드나무, 윌로우 허브 및 오토보리로부터의 추출물, 화분 및 활성 물질 및 순수 물질(예를 들면, 특히 비사보롤, 아피게닌-7-글루코시드, 보스웨릭크산(boswellic acid), 피토스테롤, 그리치르리진, 글라부리딘진 혹은 리코카르콘 A(licochalkon A)가 특히 바람직하다. 옥틸 갈레이트의 상승작용 목표 혼합물을 함유하는 조제물은 2종 이상의 항염증작용 화합물의 혼합물을 함유할 수 있다.
The cosmetic composition containing octyl gallate and the synergistic target mixture according to the present invention may contain anti-inflammatory compounds and / or activating compounds which alleviate redness and / or itching. There may be suitable, cosmetic and / or dermatological applications thereof, for which all the usual anti-inflammatory compounds and active compounds that alleviate redness and / or itch may be used. The anti-inflammatory compound used and the active compound that alleviates redness and / or itching are advantageously steroidal anti-inflammatory agents in the form of a corticosteroid, for example hydrocortisone, dexamethasone, dexamethasone phosphate, methylprednisolone or cortisone, You can expand your list by adding more steroidal anti-inflammatory drugs. Non-steroidal anti-inflammatory agents may also be used. (For example, aspirin, disalcid, sorpurin or fendoster), an acetic acid derivative (for example, diclofenac, phenoscopican, , Indomethacin, sulindadac, tolmetin or crydavik), phenamates (e.g., mefenamic, macropenamic, furfenamic or nifurmic), propionic acid derivatives such as ibuprofen, naproxen , Belloxaprofen), or a pyrazole (e.g., phenylbutazone, oxyphenylbutazone, pebra steel or azapropazone) can be exemplified. Or natural anti-inflammatory substances and substances that reduce redness and / or itching. Highly pure active substances isolated from plant extracts, particularly notably active plant extracts and plant extracts, can be used. Extracts from pollen, camomile, aloe, Commiphora species, Rubia species, willow, willow herb and carob bore, pollen and active substances and pure substances (for example, especially bisabolol, apigenin-7- Particular preference is given to seeds, boswellic acid, phytosterol, glycyrrhizin, glabridin or licochalkon A. Synergistic action of octyl gallate A preparation containing a target mixture may contain two or more May contain a mixture of anti-inflammatory compounds.
본 발명에 따른 옥틸 갈레이트의 상승작용 목표 혼합물을 함유하는 화장료 조성물은 피부 톤 개선 작용을 가지는 활성화합물을 함유할 수 있다. 이것에 관한, 화장품 및/혹은 피부과학적 적용에 적절한 것도 있고 그것들에 통상의 모든 피부 톤 개선 활성화합물을 본 발명에 따라서 사용할 수 있다. 유리한 피부 톤 개선 활성화합물은 코지산, 히드로퀴논, 알부틴, 아스코르빈산, 마그네슘 아스콜빌 포스페이트, 감초 뿌리 추출물 및 글라브리딘 혹은 리코칼톤(licochalkon) A의 성분, 루멕스(Rumex) 및 라무러스(Ramulus) 종으로 부터의 추출물, 피너스(Pinus)로부터의 추출물 및 특히 피부 톤 개선 스틸벤 유도체를 함유하는 포도 종(Vitis species)으로부터의 추출물이다.
The cosmetic composition containing the synergistic target mixture of octyl gallate according to the present invention may contain an active compound having a skin tone improving action. Any of the cosmetic and / or dermatological applications of this, and any of the usual skin tone improving active compounds, may be used in accordance with the present invention. Advantageous skin tone improving active compounds include active ingredients such as kojic acid, hydroquinone, arbutin, ascorbic acid, magnesium ascorbyl phosphate, licorice root extract and glabridin or licochalkon A components, Rumex and laminarum Extracts from Ramulus species, Extracts from Pinus and Extracts from Vitis species containing especially skin tone improving stilbene derivatives.
본 발명에 따른 옥틸 갈레이트 및 상승작용 목표 혼합물을 함유하는 화장료 조성물은 피부 썬탠 작용을 가지는 활성화합물을 함유할 수 있다. 이것에 관해서는, 화장품 및/혹은 피부과학적 적용에 적절한 것도 있고 그것들에 통상의 모든 피부 썬탠 활성화합물을 사용할 수 있다. 여기에서는 다이하이드록시아세톤 (DHA;1, 3-디히드록시-2-프로파논)을 예로서 들 수 있다. DHA는 모노머 혹은 다이머 형태의 어느 것도 존재할 수 있으며 결정 형태에 있어서는 다이머의 비율이 우세하다.
The cosmetic composition containing the octyl gallate and the synergistic target mixture according to the present invention may contain an active compound having skin tanning action. As regards this, there are also those which are suitable for cosmetic and / or dermatological applications and in which all usual skin tanning active compounds can be used. Here, dihydroxyacetone (DHA; 1,3-dihydroxy-2-propanone) is exemplified. DHA can exist in either monomeric or dimeric form, with dimer proportions predominating in crystalline form.
본 발명에 따른 옥틸 갈레이트의 상승작용 목표 혼합물을 함유하는 화장료 조성물은 또 모노-, 디 및 올리고당, 예를 들면 포도당, 갈락토스, 과당, 만노스, 과당 및 유당을 함유할 수 있다.
The cosmetic composition containing the synergistic target mixture of octyl gallate according to the present invention may also contain mono-, di and oligosaccharides such as glucose, galactose, fructose, mannose, fructose and lactose.
본 발명에 따른 옥틸 갈레이트의 상승작용 목표 혼합물을 함유하는 화장료 조성물은 통상은 완전한 식물의 추출에 의해 조제되지만, 개개의 경우에, 더욱 꽃 및/혹은 잎, 목재, 식물의 수피 혹은 독점적으로 조제되는 식물 추출물을 함유할 수 있다.
Synergistic action of octyl gallate according to the invention The cosmetic composition containing the target mixture is usually prepared by extraction of a complete plant, but in individual cases it may be further blended with flowers and / or leaves, wood, ≪ / RTI >
사용할 수 있는 식물 추출 물건에 관해서는 알로에, 해마멜리스(Hamamelis), 알게(algae), 오크 수피, 윌로우허브(willow-herb), 쐐기풀, 데드네틀(dead nettles), 호프, 카모마일, 밀포일(milfoil), 아르니카(arnica), 금잔화, 우엉의 뿌리, 버독뿌리(burdock root), 산사나무, 호톤(hawthorn), 린덴 블로섬(linden blossom), 아몬드, 소나무 잎(pine needles), 호스체스트넛(horsechestnut), 샌달우드(sandalwood), 주니퍼(juniper), 코코넛, 망고, 살구, 오렌지, 레몬, 라임, 그레이프 프루츠, 사과, 녹차, 그레이프 프루츠의 종자, 밀, 오트, 보리, 보리, 샐비어잎, 타임, 바질, 로즈메리, 버치(birch), 말로우(mallow), 타네트케바나(bitter-crass), 버드나무 수피, 레스타로(restharrow), 콜츠푸트(coltsfoot), 알테아(althaea), 한국 인삼 및 생강의 추출물이 특히 유리하다. 이러한 중에서는, 알로에, 카모마일, 알게(algae), 로즈메리, 금잔화, 한국 인삼, 오이, 샐비어잎, 쐐기풀, 린덴 블로섬(linden blossom), 아르니카 및 해마메리스(Hamamelis)로부터의 추출물이 특히 바람직하다. 2종 이상의 식물 추출물의 혼합물도 사용할 수 있다. 상기의 식물 추출물의 조제에 사용할 수 있는 추출제는 특히 물, 알코올 및 그러한 혼합물일 수 있다. 알코올 중에서는, 저급 알코올(예를 들면 에탄올 및 아이소프로판올) 그러나 다가 알코올(예를 들면 에틸렌글리콜, 프로필렌글리콜 및 부틸렌 글리콜)이 이것에 관해서, 그리고 구체적으로는 유일한 추출제로서 그리고 더욱 물과 혼합해 사용이 바람직하다. 식물 추출물은 순수 형태에도 있고 또 희석 형태에서도 사용할 수 있다.
The available plant extracts include aloe, hammamelis, algae, oak bark, willow-herb, nettles, dead nettles, hops, chamomile, milfoil such as milfoil, arnica, marigold, burdock root, burdock root, hawthorn, linden blossom, almond, pine needles, horsechestnut, , Sandalwood, juniper, coconut, mango, apricot, orange, lemon, lime, grapefruit, apple, green tea, grapefruit seeds, wheat, oats, barley, barley, sage leaf, time, basil Rosemary, birch, mallow, bitter-crass, willow bark, restharrow, coltsfoot, althaea, Korean ginseng and ginger Is particularly advantageous. Among these, extracts from aloe, chamomile, algae, rosemary, marigold, Korean ginseng, cucumber, sage leaf, nettle, linden blossom, arnica and hanamelis are particularly preferred . Mixtures of two or more plant extracts may also be used. Extractants which can be used for the preparation of the above plant extracts may in particular be water, alcohols and mixtures thereof. Among alcohols, lower alcohols (e.g., ethanol and isopropanol) but polyhydric alcohols (e.g., ethylene glycol, propylene glycol and butylene glycol) are used in this regard and specifically as a sole extractant and more Use of solutions is preferred. Plant extracts can be used in pure form or in diluted form.
본 발명에 따른 옥틸 갈레이트의 상승작용 목표 혼합물을 함유하는 화장료 조성물은 특히 결정 혹은 미세 결정 고체, 예를 들면 무기 미세 색소가 조제물중에 받아들여지는 경우에, 음이온, 양이온, 비이온 및/혹은 양이온성 계면활성제를 함유할 수 있다. 계면활성제는 유기의 비극성 물질을 수중에 용해 할 수 있는 양친매성 물질이다. 이것에 관한, 계면활성제 분자의 친수성 부분은 통상, 극성 관능기, 예를 들면, -COO-, -OSO3 2 -, -SO3 -이지만, 한편, 소수성 부분은 대체로, 비극성 탄화수소기이다. 계면활성제는 분자의 친수성 부분의 성질 및 가전에 따라서 개괄적으로 분류되며, 음이온계면활성제, 양이온 계면활성제, 양성계면활성제 및 비이온성계면활성제인 4군으로 분류할 수 있다.
The cosmetic composition containing the synergistic target mixture of octyl gallate according to the present invention is particularly suitable for the preparation of cosmetic compositions containing anionic, cationic, non-ionic and / or non-ionic cosmetic compositions, especially when crystalline or microcrystalline solids, And may contain cationic surfactants. Surfactants are amphipathic substances that can dissolve organic nonpolar materials in water. The hydrophilic portions of the surfactant molecules hereof is normal, for a polar functional group, for example, -COO -, -OSO 3 2 - , -SO 3 - , but, on the other hand, the hydrophobic part is generally a non-polar hydrocarbon group. Surfactants are broadly classified according to the properties of the hydrophilic part of the molecule and the type of the consumer, and can be classified into four groups: anionic surfactants, cationic surfactants, amphoteric surfactants and nonionic surfactants.
음이온 계면활성제는 통상, 관능기로서 카르복실산, 황산 혹은 설폰산기를 함유한다. 수용액중에서는, 그것들은 산성 혹은 중성 용매에서 음성 유기 이온을 형성한다. 양이온 계면활성제는 실질적으로 독점적으로 제4급 암모늄기의 존재를 특징으로 한다. 수용액 중에서, 그것들은 산성 혹은 중성 용매에서 양성 유기 이온을 형성한다. 양성계면활성제는 음이온 및 양이온기의 양쪽 모두를 포함해, 수용액 중에서 pH치에 따라 음이온 혹은 양이온 계면활성제와 같이 작용한다. 강산 용매 안에서는 그것들은 양성의 전하를 갖고, 알칼리성 용매 안에서는, 음성의 전하를 가진다. 그에 대해, 중성 pH영역에서는 그것들은 양이온성이다. 폴리에테르 쇠사슬은 비이온계면활성제가 전형적이다. 비이온계면활성제는 수성 용매에서 이온을 형성하지 않는다.
The anionic surfactant usually contains a carboxylic acid, a sulfuric acid or a sulfonic acid group as a functional group. In aqueous solutions, they form negative organic ions in acidic or neutral solvents. Cationic surfactants are substantially exclusively characterized by the presence of quaternary ammonium groups. In aqueous solutions, they form positive organic ions in acidic or neutral solvents. Amphoteric surfactants, including both anionic and cationic groups, act like anionic or cationic surfactants depending on the pH value in aqueous solution. In strong acid solvents, they have a positive charge, and in an alkaline solvent they have a negative charge. In contrast, in the neutral pH range they are cationic. Polyether chains are typical of non-ionic surfactants. Nonionic surfactants do not form ions in aqueous solvents.
유리하게 사용할 수 있는 음이온 계면활성제는 아실 아미노산 및 이들의 염일 수 있으며, 구체적으로 예를 들면, 소듐 아실글루타메이트, 디-TEA-팔미토일 아스팔테이트 및 소듐 카프릴/카프링르타메이트인 아실 글루탐산염; 예를 들면, 팔미토일 가수분해 유즙단백질, 소듐 코코 일-가수분해 대두 단백질 및 소듐/칼륨 코코일-가수분해 콜라겐인 아실 펩타이드; 예를 들면, 미린스토일 사르코신, TEA-라우로일 사코시네이트, 소듐 라우로일 사코시네이트 및 소듐 코코일 사코시네이트인 사코시네이트; 예를 들면, 나트륨 라우로일 타우레이트 및 나트륨 메틸 코코일 타우레이트인 타우린 산염; 아실락틸레이트, 라우로일 락틸레이트, 카프로 락틸레이트 또는 아라니네이트일 수 있다.
Anionic surfactants which may be advantageously used are acyl amino acids and salts thereof, and specifically include, for example, acyl glutamates, such as sodium acyl glutamate, di-TEA palmitoyl aspartate and sodium capryl / caprylate; For example, palmitoyl hydrolyzed milk protein, sodium cocoyl hydrolyzed soy protein and sodium / potassium cocoyl hydrolyzed collagen acyl peptide; For example, salicylate, salicyl sarcosine, TEA-lauroyl sarcosinate, sodium lauroyl sarcosinate and sodium cocoyl sarcosinate; Taurates, for example sodium lauroyl taurate and sodium methyl cocoyl taurate; Acyl lactylate, lauroyl lactylate, caprolactylate or arraninate.
또한, 유리하게 사용할 수 있는 음이온 계면활성제는 카르복실산 및 유도체일 수 있으며, 구체적으로 예를 들면, 라우린산, 스테아린산 알루미늄, 마그네슘아르카노라트 및 운데실렌 산아연; 예를 들면, 칼슘스테아로이르라크치라트, 라우리스- 6시트레이트 및 나트륨 PEG-4 라우라미드카르복실레이트인 에스테르카르복실 산; 예를 들면, 나트륨 라우리스- 13카르복실레이트 및 나트륨 PEG-6 코코아미드카르복실레이트인 에테르-카르복실산; 또는 예를 들면, DEA-오레스 10포스페이트 및 지라우레스 4포스페이트인 인산 에스테르 및 염일 수 있다.
In addition, the anionic surfactants that can be advantageously used may be carboxylic acids and derivatives, and specifically include, for example, lauric acid, aluminum stearate, magnesium arcanolato and undecylenic acid zinc; For example, ester carboxylic acids such as calcium stearoyl lactylate, laureth-6 citrate and sodium PEG-4 laura mid carboxylate; For example, ether-carboxylic acid which is sodium laisse-13 carboxylate and sodium PEG-6 cocoamidocarboxylate; Or phosphate esters and salts which are, for example, DEA-ores 10 phosphate and zeolite 4 phosphate.
또한, 유리하게 사용할 수 있는 음이온 계면활성제는 설폰산 및 염일 수 있으며, 구체적으로 예를 들면, 예를 들면, 소듐/암모늄 코코일 이세티오네이트인 아실이세티오네이트; 알킬아릴설포네이트; 예를 들면, 소듐 코코넛 모노글리세라이드 설페이트, 소듐 C12-14올레핀-설포네이트인 알킬설포네이트; 소듐 라우릴 설포 아세테이트 및 마그네슘 PEG-3 코코아미드설페이트; 또는 예를 들면, 디옥틸나트륨 설포석시네이트, 2나트륨 라우리스-설포석시네이트, 2나트륨 라우릴 설포석시네이트 및 2나트륨 운데실렌 아마이드 MEA-설포석시네이트인 설포석시네이트일 수 있다.
In addition, the anionic surfactants that may be advantageously used may be sulfonic acids and salts, and specifically include, for example, acyl isethionates such as sodium / ammonium cocoyl isethionate; Alkyl aryl sulfonates; For example, sodium coconut monoglyceride sulfate, alkylsulfonates such as sodium C12-14 olefin-sulfonate; Sodium lauryl sulfoacetate and magnesium PEG-3 cocoamide sulfate; Or diols such as, for example, dioctyl sodium sulfosuccinate, disodium lauryl sulfosuccinate, disodium lauryl sulfosuccinate, and disodium silicate amide sulfosuccinate, have.
또한, 유리하게 사용할 수 있는 음이온 계면활성제는 황산에스테르일 수 있으며, 구체적으로 예를 들면, 나트륨, 암모늄, 마그네슘, 미라(MIRA), TIPA 라우리스 설페이트, 나트륨미레스설페이트 및 나트륨 C12-13팰리스 설페이트인 알킬에테르설페이트; 또는 예를 들면, 나트륨, 암모늄 및 TEA 라우릴 설페이트인 것인 알킬설페이트일 수 있다.
In addition, the anionic surfactants that can be used advantageously can be sulfuric acid esters, and specifically include, for example, sodium, ammonium, magnesium, MIRA, TIPA laisse sulfate, sodium myrus sulfate, and sodium C12-13 palm sulphate Alkyl ether sulfates; Or an alkyl sulphate such as, for example, sodium, ammonium and TEA lauryl sulphate.
유리하게 사용할 수 있는 양이온 계면활성제는 알킬 아민, 알킬 이미다졸, 에톡실화 아민, 제4급 계면활성제 (RNH2CH2CH2COO-(pH=7에 대해), RNHCH2CH2COO-B+(pH=12에 대해) B+=임의의 양이온, 예를 들면 Na+ ) 및 제4급 에스터일 수 있다.Advantageously, the cationic surfactants include alkylamines, alkylimidazoles, ethoxylated amines, quaternary surfactants (RNH 2 CH 2 CH 2 COO- (for pH = 7), RNHCH 2 CH 2 COO-B + (for pH = 12) B + = any cation such as Na + ) and a quaternary ester.
제4급 계면활성제는 4개의 알킬 혹은 아릴기에 공유결합된 적어도 1개의 N원자를 포함한다. 이것이 pH값에 상관없이, 양성의 전하를 가져온다. 알킬 베타인, 알킬 아마이드 프로필기 베타인 및 알킬아미드프로필히드록시술파인이 유리하다. 사용되는 양이온 계면활성제는 더욱, 바람직하게는, 제4급 암모늄 화합물, 특히 염화 혹은 브롬화 벤질 트리알킬-암모늄, 예를 들면, 염화벤질 디메틸 스테아릴-암모늄, 및 더욱 알킬 트리알킬 암모늄염, 예를 들면, 염화 혹은 브롬화 세틸트리메틸암모늄, 염화 혹은 브롬화 알킬 디메틸 히드록시 에틸 암모늄, 염화 혹은 브롬화 디알킬 디메틸암모늄, 알킬 아마이드 에틸-트리메틸-암모늄 에테르설페이트, 알킬피리디늄염, 예를 들면, 염화 라우릴-혹은 세틸-피리디늄, 이미다졸린 유도체 및 산화 아민 예를 들면 알킬다이메틸아민 옥시드 혹은 알킬아미노 에틸 다이메틸아민 옥시드와 같은 양이온 특성의 화합물을 포함해서 완성되는 군으로부터 선택할 수 있다. 세틸 트리메틸-암모늄염은 특히 유리하게 사용할 수 있다.
The quaternary surfactant comprises at least one N atom covalently bonded to four alkyl or aryl groups. This leads to a positive charge regardless of the pH value. Alkyl betaines, alkyl amide propyl betaines, and alkyl amide propyl hydroxysulfates are advantageous. The cationic surfactants used are also preferably quaternary ammonium compounds, in particular benzyltrialkylammonium chlorides or bromides, such as benzyldimethylstearylammonium chloride, and furthermore alkyltrialkylammonium salts, such as, for example, , Cetyltrimethylammonium chloride or bromide, alkyldimethylhydroxyethylammonium bromide or bromide, dialkyldimethylammonium chloride or bromide, alkylamidoethyl-trimethylammonium ether sulfate, alkylpyridinium salts such as, for example, lauryl chloride or Cetyl-pyridinium, imidazoline derivatives, and oxides such as alkyldimethylamine oxides or alkylaminoethyldimethylamine oxides. Cetyltrimethylammonium salts can be used particularly advantageously.
유리하게 사용할 수 있는 양성 계면활성제는 예를 들면, 나트륨 아실 안호 아세테이트, 2나트륨 아실 안호 디프로피오네이트, 2나트륨알킬안호지아세테오트, 나트륨 아실 안호 히드록시-프로필기 설포네이트, 2나트륨 아실 안호 디아세테이트 및 나트륨 아실 안호 프로피오네이트인 아실/디알킬에틸렌디아민; 또는 예를 들면, 아미노프로필알킬글루타미드, 알킬아미노 프로피온산, 나트륨 알킬 이미드 디 프로피오네이트 및 라우로안호카르복시그리시네이트인 N-알킬아미노산일 수 있다.
Amphoteric surfactants that can be used advantageously include, for example, sodium acyl amphoacetate, disodium acyl anodipropionate, disodium alkyl anojia cetethoate, sodium acyl anhydroxy-propyl group sulfonate, disodium acyl Acyl / dialkylethylenediamine, anhydrodiacetate and sodium acylamphopropionate; Or N-alkyl amino acids which are, for example, aminopropyl alkyl glutamides, alkyl aminopropionic acids, sodium alkyl imide dipropionates and lauroanocarboxyl glycinates.
유리하게 사용할 수 있는 비이온성 계면활성제는 알코올; 예를 들면, 코코아미드 MEA/DEA/MIPA인 알칸올 아마이드; 예를 들면, 코코아미드프로필아민옥시드인 산화 아민; 산화에틸렌, 글리세롤, 소르비탄 혹은 다른 알코올과의 카르복실산의 에스터화에 의해 형성 되는 에스터; 예를 들면, 에톡실화/프로폭실 화 알코올, 에톡실화/프로폭실 화 에스터, 에톡실화/프로폭실화 글리세롤 에스터, 에톡실화/프로폭실화 콜레스테롤, 에톡실화/프로폭실화 트리글리세라이드에스테르, 에톡실화/프로폭실화 라놀린, 에톡실화/프로폭실화 폴리실록산, 프로폭실화 POE 에테르 및, 라우릴 글루코시드, 디실 글리코시드 및 코코 글리코시드와 같은 알킬폴리글리코시드인 에테르; 자당 에스터 및 에테르; 폴리글리세롤 에스터, 디글리세롤 에스터, 글리세롤 에스터; 또는 메틸 글루코스 에스터, 하이드록시산의 에스터일 수 있다.
Nonionic surfactants that can be advantageously used include alcohols; For example, alkanolamides such as cocoamide MEA / DEA / MIPA; For example, oxidized amines such as cocoamidopropylamine oxide; Esters formed by the esterification of carboxylic acids with ethylene oxide, glycerol, sorbitan or other alcohols; Propoxylated esters, ethoxylated / propoxylated glycerol esters, ethoxylated / propoxylated cholesterol, ethoxylated / propoxylated triglyceride esters, ethoxylated / propoxylated glycerol esters, Propoxylated lanolin, ethoxylated / propoxylated polysiloxanes, propoxylated POE ethers, and alkylpolyglycosides such as lauryl glucoside, decyl glycoside and cocoglycoside; Sucrose esters and ethers; Polyglycerol ester, diglycerol ester, glycerol ester; Or an ester of a methyl ester, a hydroxy acid.
1종 이상의 비이온성계면활성제와의 음이온 성 및/혹은 양성계면활성제의 편성물의 사용도 유리하다. 세정력 물질은 1,2-알칸 다이올의 상승작용 목표 혼합물을 함유하는 본 발명에 따른 조제물중에, 조제물의 총중량에 근거해, 1 ~ 98%(w/w)의 사이의 농도로 존재할 수 있다.
Use of anionic and / or amphoteric surfactants with one or more nonionic surfactants is also advantageous. The detergent substance may be present in the preparation according to the invention containing the synergistic target mixture of the 1,2-alkanediol at a concentration of between 1 and 98% (w / w), based on the total weight of the preparation .
본 발명에 따른 옥틸 갈레이트 및 상승작용 목표 혼합물을 함유하는 화장품 혹은 화장료 조성물은 또 에멀젼의 형태로 존재할 수 있다. The cosmetic or cosmetic composition containing octyl gallate and the synergistic target mixture according to the present invention may also be present in the form of an emulsion.
유상은 유리하게는 광유, 광물 왁스; 지방유, 지방, 왁스 및 다른 천연 및 합성 지방 물질, 바람직하게는 저탄소수를 가지는 알코올(예를 들면 아이소프로판올, 프로필린글리콜 혹은 글리세롤)과의 지방산의 에스터, 또는 저탄소수를 가지는 알칸산 혹은 지방산과의 지방알코올의 에스터; 벤조산 알킬; 또는 실리콘오일(예를 들면 다이메타이콘, 다이에틸 폴리실록산, 디페닐 폴리실록산) 및 그러한 혼합 형태; 로부터 선택할 수 있다.
The oil phase is advantageously mineral oil, mineral wax; Esters of fatty acids with alcohols (e. G. Isopropanol, propylene glycol or glycerol), or alkanoic acids or fatty acids having low carbon numbers, with fatty acids, fats, oils, waxes and other natural and synthetic fatty substances, Esters of fatty alcohols; Alkyl benzoate; Or silicone oils (e.g., dimethicone, diethylpolysiloxane, diphenylpolysiloxane) and mixtures thereof; .
(a) 3~30 C원자의 길이을 가지는 포화 및/혹은 불포화의 분지 및/혹은 직쇄 알칸카르복실산 및, 3~30 탄소원자의 길이를 가지는 포화 및/혹은 불포화의 분지 및/혹은 직쇄 알코올의 에스터, (b) 방향성 족 카르복실산 3~30 탄소원자의 길이를 가지는 포화 및/혹은 불포화의 분지 및/혹은 직쇄 알코올의 에스터를 유리하게 사용할 수 있다. 바람직한 에스터 기름은 N테트라데카논산 이소프로필, 팔미틴 산 이소프로필, 스테아린 산 이소프로필, 올레산 이소프로필, 스테아린산 n-부틸, 라우린산 n-헥실, 올레산 n-디실, 스테아린 산 이소옥틸, 스테아린 산 이소 노닐, 이소노난 산이소 노닐, 팔미틴 산2-에틸헥실, 라우린산2-에틸헥실, 스테아린 산2-헥실데실, 팔미틴 산2-옥틸 도데실, 올레산 나 일, 에루스산 나 일, 오레인산에르실, 에르카산에르실 및, 이러한 에스터의 합성, 반합성 및 천연의 혼합물, 예를 들면 죠죠바유이다.
(a) Saturated and / or unsaturated branched and / or straight chain alkanecarboxylic acids having a length of 3 to 30 C atoms and saturated and / or unsaturated branched and / or straight chain alcohol esters having a length of from 3 to 30 carbon atoms , (b) Branched carboxylic acid esters of saturated and / or unsaturated branched and / or straight chain alcohols having a length of from 3 to 30 carbon atoms can be advantageously used. Preferred ester oils are isopropyl Ntetradecanoate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, iso-stearate Nonyl, isonononanoic acid isononyl, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, nail oleic acid, erucic acid nail, oleic acid Erucyl, erucic acid, and the synthesis of these esters, semisynthetic and natural mixtures, such as Jovovaya.
또한, 유상은 유리하게는, 분지 및 직쇄 탄화수소 및 왁스, 실리콘오일, 디알킬에테르를 포함해서 완성되는 군, 포화 혹은 불포화의 분지 혹은 직쇄 알코올 및 더욱 지방산 트리글리세라이드, 구체적으로는 8~24, 특히 12~18 탄소 원자의 길이를 가지는 포화 및/혹은 불포화의 분지 및/혹은 직쇄 알칸카르복실산의 트리글리세롤 에스터를 포함해서 완성되는 군으로부터 선택할 수 있다. 지방산 트리글리세라이드는 유리하게는, 합성, 반합성, 및 천연유(예를 들면, 올리브유, 해바라기유, 대두유, 낙화생유, 평지씨기름, 아몬드유, 야자유, 코코넛 기름, 야자의 심유등)를 포함해서 완성되는 군으로부터 선택할 수 있다. 이러한 기름 및 왁스 성분의 임의의 혼합물도 또 유리하게 사용할 수 있다. 경우에 따라서는, 더욱, 유상의 단독 지방 성분으로서 왁스(예를 들면 팔미틴산 세틸)를 사용하는 것도 유리하다라고 하는 것이 있어 유상은 유리하게는, 이소 스테아린 산 2-에틸헥실, 옥틸 도데카놀, 이소노난 산이소 트리데실, 이소 에이코산, 코코아 산2-에틸헥실, 벤조산 C12-C15-알킬, 카프릴산/카프르산 트리글리세라이드 및 지카프리리르에이텔로부터 완성되는 군으로부터 선택된다. 벤조산 C12-C15-알킬과 이소 스테아린 산2-에틸헥실의 혼합물, 벤조산 C12-C15-알킬과 이소노난 산이소 트리데실의 혼합물 및 벤조산 C12-C15-알킬, 이소노난 산2-에틸헥실 및 이소노난 산이소 트리데실의 혼합물은 특히 유리하다. 탄화수소의 유동파라핀, 스쿠알란 및 스쿠알렌도 유리하게 사용할 수 있다. 유상은 유리하게는 더욱, 환식 혹은 선상 실리콘오일을 함유할 수도 있고 이러한 기름만으로 부터 완성될 수 있지만, 그러나, 여기서 1종 혹은 복수의 실리콘오일에 더해 다른 유상성분을 더욱 함유하는 것이 바람직하다. 사이클로메티콘(예를 들면, 데카메틸 사이클로펜타실록산)은 실리콘오일로서 유리하게 사용할 수 있다. 그러나, 다른 실리콘오일, 예를 들면, 운데카 메틸 사이클로 실록산, 폴리디 메틸 실록산 및 폴리(메틸-페닐 실록산)도 유리하게 사용할 수 있다. 또한, 사이클로메티콘과 이소노난 산이소 트리데실의 혼합물 및 사이클로메티콘과 이소 스테아린 산2-에틸헥실의 혼합물도 특히 유리하다. The oil phase is advantageously selected from the group consisting of branched and straight chain hydrocarbons and waxes, silicone oils, groups completed with dialkyl ethers, saturated or unsaturated branched or straight chain alcohols, and also fatty acid triglycerides, specifically from 8 to 24, And a triglycerol ester of saturated and / or unsaturated branched and / or straight chain alkanecarboxylic acids having a length of 12 to 18 carbon atoms. Fatty acid triglycerides are advantageously included in the composition of the present invention including synthetic, semisynthetic and natural oils (such as olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, You can choose from the complete group. Any mixture of such oil and wax ingredients may also be used to advantage. In some cases, it is also advantageous to use wax (for example, cetyl palmitate) as the oil component of the oil phase. The oil phase is advantageously selected from 2-ethylhexyl isostearate, octyldodecanol, iso Iso-octanoic acid, 2-ethylhexyl cocoate, C12-C15-alkyl benzoic acid, caprylic acid / capric acid triglyceride and gicaprylyl acetate. A mixture of benzoic acid C12-C15-alkyl and 2-ethylhexyl isostearate, a mixture of benzoic acid C12-C15-alkyl and isononanate isotridecyl and a mixture of benzoic acid C12-C15-alkyl, 2-ethylhexyl isononanoate and isononane Mixtures of acid isotridecyl are particularly advantageous. The liquid paraffin, squalane and squalene of hydrocarbons can also be used advantageously. The oil phase advantageously may further comprise a cyclic or linear silicone oil and may be completed solely with such oil, but it is preferred that it further contains other oil components in addition to the one or more silicone oils. Cyclomethicone (for example, decamethylcyclopentasiloxane) can be advantageously used as a silicone oil. However, other silicone oils such as undecamethylcyclosiloxane, polydimethylsiloxane and poly (methyl-phenylsiloxane) can also be used to advantage. Mixtures of cyclomethicone and isononanate isotridecyl and mixtures of cyclomethicone and 2-ethylhexyl isostearate are also particularly advantageous.
본 발명에 따라서 옥틸 갈레이트 상승작용 목표 혼합물을 함유해, 한편 에멀젼의 형태에 있는 조제물의 수상은, 저탄소수를 가지는 알코올, 다이올 혹은 폴리올 및 더욱 그러한 에테르(바람직하게는, 에탄올, 아이소프로판올, 프로필린글리콜, 글리세롤, 에틸렌글리콜, 에틸렌글리콜 에틸 혹은 모노부틸에테르, 프로필린글리콜 모노메틸, 에틸 혹은 모노부틸에테르, 다이에틸렌글리콜 모노메틸 혹은 에틸에테르) 및 유사 제품 및 더욱 저탄소수를 가지는 알코올(예를 들면, 에탄올, 아이소프로판올, 1,2-프로판다이올글리세롤) 및 더욱 특히, 유리하게는 이산화 규소, 규산염알루미늄, 다당류 및 그러한 유도체(예를 들면, 하이알루론산, 잔탄검, 히드록시프로필 메틸셀룰로스)를 포함해서 완성되는 군으로부터, 그리고 특히 유리하게는, 폴리아크릴레이트, 바람직하게는 각각 그것들 자체에서도 있고 조합, 이른바 카보포르(예를 들면, 타입 980, 981, 1382, 2984, 5984의 카보포르)를 포함해서 완성되는 군으로부터의 폴리아크릴레이트를 포함해서 완성되는 군으로부터 선택할 수 있는 1종 혹은 복수의 증점제를 포함해서 완성될 수 있다.
The aqueous phase of the preparation in the form of an emulsion, containing the aimed mixture of octyl gallate in accordance with the invention, can be obtained by reacting an alcohol, a diol or a polyol having a low carbon number and furthermore such an ether (preferably ethanol, isopropanol, Propylene glycol monomethyl, ethyl or monobutyl ether, diethylene glycol monomethyl or ethyl ether) and similar products and alcohols having a lower carbon number (e.g., propylene glycol monomethyl ether, propylene glycol monomethyl ether, ethylene glycol monomethyl ether, ethylene glycol monomethyl ether, (For example, ethanol, isopropanol, 1,2-propanediol glycerol) and more particularly, silicon dioxide, aluminum silicate, polysaccharides and derivatives thereof such as hyaluronic acid, xanthan gum, hydroxypropyl methylcellulose, , And particularly advantageously from the group consisting of polyacrylates, Preferably from the group consisting of the polyacrylates from the group completed, including the combinations themselves, the so-called carbophores (for example, carbopols of type 980, 981, 1382, 2984, 5984) It can be completed by including one or more thickeners that can be selected.
본 발명에 따라, 한편 에멀젼의 형태에 있는 옥틸 갈레이트의 상승작용 목표 혼합물을 함유하는 조제물은 유리하게는 1종 혹은 복수의 유화제를 함유 한다. O/W 유화 제는 예를 들면 유리하게는, 예를 들면 폴리에이톡실화 혹은 폴리프로폭실화 또는 폴리에이톡실화, 한편 폴리프로폭실화된 제품, 예를 들면, 지방알코올 에톡시레이트; 에톡실화 양모 왁스 알코올; 일반식 R-O-(-CH2-CH2-O-)n-R'의 폴리에틸렌글리콜 에테르; 일반식 R-COO-(-CH2-CH2-O-)n-H의 지방산 에톡시레이트; 일반식 R-COO-(-CH2-CH2-O-)2-R'의 에테르화 지방산 에톡시레이트; 일반식 R-COO-(-CH2-CH2-O-)n-C(O)-R'의 에스터화 지방산 에톡시레이트; 폴리에틸렌글리콜 글리세롤 지방산 에스터; 에톡실화 소르비탄 에스터; 콜레스테롤 에톡시레이트; 에톡실화 트리글리세라이드; 일반식 R-COO-(-CH2-CH2-O-)n-OOH(n는5~30의 수를 나타낸다)의 알킬에테르카르본 산; 폴리옥시에틸렌 소르비톨 지방산 에스터; 일반식 R-O-(-CH2-CH2-O-)n-SO3-H의 알킬에테르설페이트; 일반식 R-O-(-CH2-CH(CH3)-O-)n-H의 지방알코올 프로폭시라트; 일반식 R-O-(-CH2-CH(CH3)-O-)n-R'의 폴리프로필렌글리콜 에테르; 프로폭실화 양모 왁스 알코올; 일반식 R-COO-(-CH2-CH(CH3)-O-)n-R'의 에스터화 지방산 프로폭시라트; 일반식 R-COO-(-CH2-CH(CH3)-O-)n-C(O)-R'의 에스터화 지방산 프로폭시라트; 일반식 R-COO-(-CH2-CH(CH3)-O-)n-H의 지방산 프로폭시라트; 프로필린글리콜 글리세롤 지방산 에스터; 프로폭실화 소르비탄 에스터; 코레스테로르프로폭시라트; 프로폭실화 트리글리세라이드; 일반식 R-O-(-CH2-CH(CH3)-O-)n-CH2-COOH의 알킬에테르카르본 산; 일반식 R-O-(-CH2-CH(CH3)-O-)n-SO3-H의 알킬에테르설페이트 및 이러한 설페이트에 기초한 산; 일반식 R-O-Xn-Ym-H의 지방알코올 에톡시레이트/프로폭시라트; 일반식 R-O-Xn-Ym-R'의 폴리프로필렌글리콜 에테르; 일반식 R-COO-Xn-Ym-R'의 에스터화 지방산 프로폭시라트; 및 일반식 R-COO-Xn-Ym-H의 지방산 에톡시레이트/프로폭시라트; 를 포함하는 군으로부터 선택할 수 있다.
According to the invention, the preparations containing the synergistic target mixture of octyl gallate in the form of emulsions on the one hand advantageously contain one or more emulsifiers. O / W emulsifiers are, for example, advantageously, for example, polyethoxylated or polypropoxylated or polyethoxylated, while polypropoxylated products such as fatty alcohol ethoxylates; Ethoxylated wool wax alcohols; The general formula RO - (- CH 2 -CH 2 -O-) nR ' of polyethylene glycol ethers; The general formula R-COO - (- CH 2 -CH 2 -O-) fatty acid ethoxylates of nH; The general formula R-COO - (- CH 2 -CH 2 -O-) 2 -R ' of the etherified fatty acid ethoxylates; The general formula R-COO - (- CH 2 -CH 2 -O-) n -C (O) -R esterified fatty acid ethoxylates of the "; Polyethylene glycol glycerol fatty acid esters; Ethoxylated sorbitan esters; Cholesterol ethoxylate; Ethoxylated triglyceride; The general formula R-COO - (- CH 2 -CH 2 -O-) n -OOH (n is the number of 5 to 30) alkyl ether carboxylic acid; Polyoxyethylene sorbitol fatty acid esters; The general formula RO - (- CH 2 -CH 2 -O-) in the alkyl ether sulfate n-SO 3 -H; The general formula RO - (- CH 2 -CH ( CH 3) -O-) nH of fatty alcohols propoxy Montserrat; The general formula RO - (- CH 2 -CH ( CH 3) -O-) nR ' of the polypropylene glycol ethers; Propoxylated wool wax alcohol; The general formula R-COO - (- CH 2 -CH (CH 3) -O-) nR ' of the esterified fatty acids propoxy Montserrat; The general formula R-COO - (- CH 2 -CH (CH 3) -O-) nC (O) -R ' of the esterified fatty acids propoxy Montserrat; The general formula R-COO - (- CH 2 -CH (CH 3) -O-) nH of fatty propoxy Montserrat; Propyleneglycol glycerol fatty acid ester; Propoxylated sorbitan esters; Cholesterol propoxylate; Propoxylated triglyceride; Alkyl ether carboxylic acids of the general formula RO - (- CH 2 - CH (CH 3 ) - O--) n - CH 2 -COOH; Alkyl ether sulfates of the formula RO - (- CH 2 --CH (CH 3 ) - O--) n --SO 3 --H and acids based on such sulfates; Fatty alcohol ethoxylate / propoxylate of formula RO-Xn-Ym-H; Polypropylene glycol ethers of the general formula RO-Xn-Ym-R '; Esterified fatty acid propoxylates of the general formula R-COO-Xn-Ym-R '; And fatty acid ethoxylates / propoxylates of the general formula R-COO-Xn-Ym-H; ≪ / RTI >
본 발명에 따라서 사용되는 폴리에이톡실화 혹은 폴리프로폭실화 혹은 폴리에이톡실화 한편, 폴리프로폭실화 O/W 유화제는 특히 유리하게는, O/W 유화제가 포화기 R 및 R'를 함유하는 한, 11~18의 HLB치, 지극히 특히 유리하게는 14.5 ~ 15.5의 HLB 수치를 가지는 물질을 포함해서 완성되는 군으로부터 선택된다. O/W 유화제가 불포화기R 및/혹은 R'를 함유하든가 또는, 이소알킬 유도체가 존재하는 경우에는, 이러한 유화제의 바람직한 HLB 수치는 그것보다 낮을 수도 있고 높을 가능성도 있다 Polypropoxylated or polyethoxylated polyethoxylated or polyethoxylates used according to the invention. On the other hand, the polypropoxylated O / W emulsifiers are particularly advantageously characterized in that the O / W emulsifiers contain saturated radicals R and R ' , An HLB value of 11 to 18, and very particularly advantageously a material having an HLB value of 14.5 to 15.5. If the O / W emulsifier contains an unsaturated group R and / or R ', or if an isoalkyl derivative is present, the preferred HLB level of such an emulsifier may be lower or higher than that
지방알코올 에톡시레이트를 에톡실화 스테아릴알코올, 세틸알코올, 세틸스테아릴알코올(세테알릴알코올)을 포함해서 완성되는 군으로부터 선택하는 것이 유리하다. 아래와 같은 것이 특히 바람직하다. It is advantageous to select the fatty alcohol ethoxylate from the group comprising ethoxylated stearyl alcohol, cetyl alcohol, cetylstearyl alcohol (cetearyl alcohol). The following is particularly preferable.
폴리에틸렌글리콜(13) 스테아릴 에테르(스테아레스 13), Polyethylene glycol (13) stearyl ether (Stearase 13),
폴리에틸렌글리콜(14) 스테아릴 에테르(스테아레스 14), Polyethylene glycol (14) stearyl ether (Stearath 14),
폴리에틸렌글리콜(15) 스테아릴 에테르(스테아레스 15), Polyethylene glycol (15) stearyl ether (Stearase 15),
폴리에틸렌글리콜(16) 스테아릴 에테르(스테아레스 16), Polyethylene glycol (16) stearyl ether (Stearos 16),
폴리에틸렌글리콜(17) 스테아릴 에테르(스테아레스 17), Polyethylene glycol (17) stearyl ether (Stearath 17),
폴리에틸렌글리콜(18) 스테아릴 에테르(스테아레스 18), Polyethylene glycol (18) stearyl ether (Stearos 18),
폴리에틸렌글리콜(19) 스테아릴 에테르(스테아레스 19), Polyethylene glycol (19) stearyl ether (Stearath 19),
폴리에틸렌글리콜(20) 스테아릴 에테르(스테아레스 20), Polyethylene glycol (20) stearyl ether (Stear 20),
폴리에틸렌글리콜(12) 이소 스테아릴 에테르(이소스테아레스 12), Polyethylene glycol (12) Isostearyl ether (Isostearase 12),
폴리에틸렌글리콜(13) 이소 스테아릴 에테르(이소스테아레스 13), Polyethylene glycol (13) isostearyl ether (Isostearase 13),
폴리에틸렌글리콜(14) 이소 스테아릴 에테르(이소스테아레스 14), Polyethylene glycol (14) isostearyl ether (Isostearase 14),
폴리에틸렌글리콜(15) 이소 스테아릴 에테르(이소스테아레스 15), Polyethylene glycol (15) Isostearyl ether (Isostearase 15),
폴리에틸렌글리콜(16) 이소 스테아릴 에테르(이소스테아레스 16), Polyethylene glycol (16) isostearyl ether (Isostearase 16),
폴리에틸렌글리콜(17) 이소 스테아릴 에테르(이소스테아레스 17), Polyethylene glycol (17) isostearyl ether (Isostear 17),
폴리에틸렌글리콜(18) 이소 스테아릴 에테르(이소스테아레스 18), Polyethylene glycol (18) isostearyl ether (Isostearase 18),
폴리에틸렌글리콜(19) 이소 스테아릴 에테르(이소스테아레스 19), Polyethylene glycol (19) isostearyl ether (Isostearase 19),
폴리에틸렌글리콜(20) 이소 스테아릴 에테르(이소스테아레스 20), Polyethylene glycol (20) isostearyl ether (Isostearase 20),
폴리에틸렌글리콜(13) 세틸에테르(세테스 13), Polyethylene glycol (13) Cetyl ether (Ceteth 13),
폴리에틸렌글리콜(14) 세틸에테르(세테스 14), Polyethylene glycol (14) Cetyl ether (Ceteth 14),
폴리에틸렌글리콜(15) 세틸에테르(세테스 15) Polyethylene glycol (15) Cetyl ether (Ceteth 15)
폴리에틸렌글리콜(16) 세틸에테르(세테스 16), Polyethylene glycol (16) Cetyl ether (Ceteth 16),
폴리에틸렌글리콜(17) 세틸에테르(세테스 17), Polyethylene glycol (17) Cetyl ether (Ceteth 17),
폴리에틸렌글리콜(18) 세틸에테르(세테스 18), Polyethylene glycol (18) Cetyl ether (Ceteth 18),
폴리에틸렌글리콜(19) 세틸에테르(세테스 19), Polyethylene glycol (19) Cetyl ether (Ceteth 19),
폴리에틸렌글리콜(20) 세틸에테르(세테스 20), Polyethylene glycol (20) cetyl ether (Ceteth 20),
폴리에틸렌글리콜(13) 이소세틸 에테르(이소세테스 13), Polyethylene glycol (13) isocetyl ether (isoceteth 13),
폴리에틸렌글리콜(14) 이소세틸 에테르(이소세테스 14), Polyethylene glycol (14) Isocetyl ether (Isocetes 14),
폴리에틸렌글리콜(15) 이소세틸 에테르(이소세테스 15), Polyethylene glycol (15) isocetyl ether (isoceteth 15),
폴리에틸렌글리콜(16) 이소세틸 에테르(이소세테스 16), Polyethylene glycol (16) Isocetyl ether (Isocetes 16),
폴리에틸렌글리콜(17) 이소세틸 에테르(이소세테스 17), Polyethylene glycol (17) Isocetyl ether (Isocetes 17),
폴리에틸렌글리콜(18) 이소세틸 에테르(이소세테스 18), Polyethylene glycol (18) Isocetyl ether (Isocetes 18),
폴리에틸렌글리콜(19) 이소세틸 에테르(이소세테스 19), Polyethylene glycol (19) Isocetyl ether (Isocetes 19),
폴리에틸렌글리콜(20) 이소세틸 에테르(이소세테스 20), Polyethylene glycol (20) isocetyl ether (isoceteth 20),
폴리에틸렌글리콜(12) 올레일 에테르(오레스 12), Polyethylene glycol (12) oleyl ether (Ores 12),
폴리에틸렌글리콜(13) 올레일 에테르(오레스 13), Polyethylene glycol (13) oleyl ether (Ores 13),
폴리에틸렌글리콜(14) 올레일 에테르(오레스 14), Polyethylene glycol (14) oleyl ether (Ores 14),
폴리에틸렌글리콜(15) 올레일 에테르(오레스 15), Polyethylene glycol (15) oleyl ether (Ores 15),
폴리에틸렌글리콜(12) 라우릴 에테르(라우리스-12), Polyethylene glycol (12) lauryl ether (lauryl-12),
폴리에틸렌글리콜(12) 이소 라우릴 에테르(이소 라우리스-12), Polyethylene glycol (12) isoleyl ether (iso-lauryl-12),
폴리에틸렌글리콜(13) 세틸 스테아릴 에테르(세테아레스 13), Polyethylene glycol (13) cetyl stearyl ether (Cetearyl 13),
폴리에틸렌글리콜(14) 세틸 스테아릴 에테르(세테아레스 14), Polyethylene glycol (14) cetyl stearyl ether (Cetearyl 14),
폴리에틸렌글리콜(15) 세틸 스테아릴 에테르(세테아레스 15), Polyethylene glycol (15) Cetyl stearyl ether (Cetearyl 15),
폴리에틸렌글리콜(16) 세틸 스테아릴 에테르(세테아레스 16), Polyethylene glycol (16) cetyl stearyl ether (Cetearyl 16),
폴리에틸렌글리콜(17) 세틸 스테아릴 에테르(세테아레스 17), Polyethylene glycol (17) cetyl stearyl ether (Cetearyl 17),
폴리에틸렌글리콜(18) 세틸 스테아릴 에테르(세테아레스 18), Polyethylene glycol (18) cetyl stearyl ether (Cetearyl 18),
폴리에틸렌글리콜(19) 세틸 스테아릴 에테르(세테아레스 19), Polyethylene glycol (19) cetyl stearyl ether (Cetearyl 19),
폴리에틸렌글리콜(20) 세틸 스테아릴 에테르(세테아레스 20).
Polyethylene glycol (20) Cetyl stearyl ether (Cetearyl 20).
지방산 에톡시레이트를 아래와 같은 군으로부터 선택할 수도 있다. The fatty acid ethoxylate may be selected from the following group.
폴리에틸렌글리콜(20) 스테어 레이트, 폴리에틸렌글리콜(21) 스테어 레이트, 폴리에틸렌글리콜(22) 스테어 레이트, 폴리에틸렌글리콜(23) 스테어 레이트, 폴리에틸렌글리콜(24) 스테어 레이트, 폴리에틸렌글리콜(25) 스테어 레이트, 폴리에틸렌글리콜(12) 이소 스테어 레이트, 폴리에틸렌글리콜(13) 이소 스테어 레이트, 폴리에틸렌글리콜(14) 이소 스테어 레이트, 폴리에틸렌글리콜(15) 이소 스테어 레이트, 폴리에틸렌글리콜(16) 이소 스테어 레이트, 폴리에틸렌글리콜(17) 이소 스테어 레이트, 폴리에틸렌글리콜(18) 이소 스테어 레이트, 폴리에틸렌글리콜(19) 이소 스테어 레이트, 폴리에틸렌글리콜(20) 이소 스테어 레이트, 폴리에틸렌글리콜(21) 이소 스테어 레이트, 폴리에틸렌글리콜(22) 이소 스테어 레이트, 폴리에틸렌글리콜(23) 이소 스테어 레이트, 폴리에틸렌글리콜(24) 이소 스테어 레이트 폴리에틸렌글리콜(25) 이소 스테어 레이트, 폴리에틸렌글리콜(12) 올레에이트, 폴리에틸렌글리콜(13) 올레에이트, 폴리에틸렌글리콜(14) 올레에이트, 폴리에틸렌글리콜(15) 올레에이트, 폴리에틸렌글리콜(16) 올레에이트, 폴리에틸렌글리콜(17) 올레에이트, 폴리에틸렌글리콜(18) 올레에이트, 폴리에틸렌글리콜(19) 올레에이트, 폴리에틸렌글리콜(20) 올레에이트.
Polyethylene Glycol (20) Stearate, Polyethylene Glycol (21) Stearate, Polyethylene Glycol 22 Stearate, Polyethylene Glycol 23 Stearate, Polyethylene Glycol 24 Stearate, Polyethylene Glycol 25, Stearate, polyethylene glycol (12) isostearate, polyethylene glycol (13) isostearate, polyethylene glycol (14) isostearate, polyethylene glycol (15) isostearate, polyethylene glycol Stearate, polyethylene glycol (17) isostearate, polyethylene glycol (18) isostearate, polyethylene glycol (19) isostearate, polyethylene glycol (20) isostearate, polyethylene glycol Stearate, polyethylene glycol (22) isostearate, polyethylene glycol (23) isostearate, polyethylene Recolour (24) Isostearate Polyethylene glycol (25) isostearate, polyethylene glycol (12) oleate, polyethylene glycol (13) oleate, polyethylene glycol (14) oleate, polyethylene glycol Polyethylene glycol (16) oleate, polyethylene glycol (17) oleate, polyethylene glycol (18) oleate, polyethylene glycol (19) oleate, polyethylene glycol (20) oleate.
소듐 라우릴-11카르복실레이트는 에톡실화 알킬에테르카르본 산 혹은 그 염으로서 유리하게 사용할 있다. 소듐 라우릴 1~4 설페이트는 알킬에테르설페이트로서 유리하게 사용할 수 있다. 폴리에틸렌글리콜(30) 콜레스테릴 에테르는 에톡실화 콜레스테롤 유도체로서 유리하게 사용할 수 있다. 폴리에틸렌글리콜(25) 소야스테로르도 또한 유용하다라고 하는 것이 증명되었다. 폴리에틸렌글리콜(60) 달맞이꽃 글리세라이드는 에톡실화 트리글리세라이드로서 유리하게 사용할 수 있다.
Sodium lauryl-11 carboxylate can be advantageously used as an ethoxylated alkyl ether carboxylic acid or salt thereof. Sodium lauryl 1-4 sulfate can be used advantageously as an alkyl ether sulfate. Polyethylene glycol (30) Cholesteryl ether can be advantageously used as an ethoxylated cholesterol derivative. Polyethylene glycol (25) soya sterols have also proven to be useful. Polyethylene glycol (60) evening primrose glycerides can be used advantageously as ethoxylated triglycerides.
또한, 폴리에틸렌글리콜 글리세롤 지방산 에스터를, 폴리에틸렌글리콜(20) 글리세릴 라우레이트, 폴리에틸렌 글리콜(21) 글리세릴 라우레이트, 폴리에틸렌글리콜(22) 글리세릴 라우레이트, 폴리에틸렌글리콜(23) 글리세릴 라우레이트, 폴리에틸렌글리콜(6) 글리세릴카프레이트/카프리네이트, 폴리에틸렌글리콜(20) 글리세릴 올레에이트, 폴리에틸렌글리콜(20) 글리세릴 이소 스테어 레이트, 폴리에틸렌글리콜(18) 글리세릴 올레에이트/코코 에이트를 포함하는 군으로부터 선택될 수도 있다.
The polyethylene glycol glycerol fatty acid ester may also be used in combination with polyethylene glycols such as polyethylene glycol (20) glyceryl laurate, polyethylene glycol (21) glyceryl laurate, polyethylene glycol (22) glyceryl laurate, polyethylene glycol (23) glyceryl laurate, Glycol (6) glyceryl caprate / caprinate, polyethylene glycol (20) glyceryl oleate, polyethylene glycol (20) glyceryl isostearate, polyethylene glycol (18) glyceryl oleate / cocoate ≪ / RTI >
소르비탄 에스터는 폴리에틸렌글리콜(20) 소르비탄 모노라우레이트; 폴리에틸렌글리콜(20) 소르비탄 물건 스테어 레이트; 폴리에틸렌글리콜(20) 소르비탄 물건 이소 스테어 레이트; 폴리에틸렌글리콜(20) 소르비탄 모노팔미테이트; 폴리에틸렌글리콜(20) 소르비탄 모노올레이트; 를 포함하는 군으로부터 선택할 수도 있다.
Sorbitan esters include polyethylene glycol (20) sorbitan monolaurate; Polyethylene glycol (20) sorbitan stuff stearate; Polyethylene glycol (20) sorbitan isostearate; Polyethylene glycol (20) sorbitan monopalmitate; Polyethylene glycol (20) sorbitan monooleate; And the like.
바람직한 W/O 유화제로써 이하를 사용할 수 있다: 8~30 탄소 원자를 가지는 지방알코올, 8~24, 특히 12~18 탄소 원자의 길이를 가지는 포화 및/혹은 불포화의 분지 및/혹은 직쇄 알칸카르복실산의 글리세롤 에스터, 8~24, 특히 12~18의 탄소 원자의 길이를 가지는 포화 및/혹은 불포화의 분지 및/혹은 직쇄 알칸카르복실산의 디글리세롤 에스터, 8~24, 특히 12~18의 탄소 원자의 길이를 가지는 포화 및/혹은 불포화의 분지 및/혹은 직쇄 알코올의 글리세롤 에테르 8~24, 특히 12~18의 탄소 원자의 길이를 가지는 포화 및/혹은 불포화의 분지 및/혹은 직쇄 알코올의 디글리세롤 에테르 8~24, 특히 12~18 탄소 원자의 길이를 가지는 포화 및/혹은 불포화의 분지 및/혹은 직쇄 알칸카르복실산의 프로필린글리콜 에스터, 및 8~24, 특히 12~18 탄소 원자의 길이를 가지는 포화 및/혹은 불포화의 분지 및/혹은 직쇄 알칸카르복실산의 소르비탄 에스터. As preferred W / O emulsifiers, the following can be used: fatty alcohols having 8 to 30 carbon atoms, saturated and / or unsaturated branched and / or straight chain alkanecarboxylic acids having a length of 8 to 24, in particular 12 to 18 carbon atoms Glycerol esters of acids, diglycerol esters of saturated and / or unsaturated branched and / or straight chain alkanecarboxylic acids having a length of from 8 to 24, in particular 12 to 18 carbon atoms, 8 to 24, in particular 12 to 18 carbon Glycerol ethers of saturated and / or unsaturated branches and / or straight chain alcohols having a length of atoms of from 8 to 24, in particular saturated and / or unsaturated branched and / or straight chain alcohols having a length of from 12 to 18 carbon atoms, diglycerol Propyleneglycol esters of saturated and / or unsaturated branched and / or straight chain alkanecarboxylic acids having a length of from 8 to 24, in particular 12 to 18, carbon atoms and from 8 to 24, in particular from 12 to 18 carbon atoms in length The saturation and / or fire Sorbitan esters of Chemistry branched and / or straight-chain alkane carboxylic acids.
특히 유리한 W/O 유화제는 글리세릴 모노스테아레이트, 글리세릴 이소 스테어 레이트, 글리세릴 미리스테이트, 글리세릴 모노올레이트, 디글리세릴 스테어 레이트, 디글리세릴 이소 스테어 레이트, 프로필린글리콜 스테어 레이트, 프로필린글리콜 이소 스테어 레이트, 프로필린글리콜 카프리 레이트, 프로필린글리콜 모노라우레이트, 소르비탄 이소 스테어 레이트, 소르비탄 모노라우레이트, 소르비탄 카프리 레이트, 소르비탄 이소 올레에이트, 수크로스 디스테아레이트, 세틸알코올, 스테아릴알코올, 아라키 질 알코올, 베헤닐알코올이소 베헤닐알코올, 셀라킬알코올, 키밀알코올, 폴리에틸렌글리콜(2) 스테아릴 에테르(스테아레스-2), 글리세릴 모노라우레이트, 글리세릴모노카프리네이트, 글리세릴 모노 카프릴레이트이다.
Particularly advantageous W / O emulsifiers are glyceryl monostearate, glyceryl isostearate, glyceryl myristate, glyceryl monooleate, diglyceryl stearate, diglyceryl isostearate, propyleneglycol stearate, Propyleneglycol monolaurate, sorbitan isostearate, sorbitan monolaurate, sorbitan caprylate, sorbitan isoleate, sucrose fatty acid esters, (2) stearyl ether (stearyl-2), glyceryl monolaurate (stearyl alcohol), stearyl alcohol, stearyl alcohol, arachidic alcohol, behenyl alcohol, isobenyl alcohol, , Glyceryl monocaprate, and glyceryl monocaprylate.
또 하나의 양태로서, 본 발명은 옥틸 갈레이트 및 보존제(1,2-알칸 다이올)을 유효 성분으로 함유하는 의약외품 조성물을 제공할 수 있다. 즉, 본 발명의 조성물은 항균활성이 요구되는 의약외품 조성물일 수 있다.
As another embodiment, the present invention can provide a quasi-product composition containing octyl gallate and a preservative (1,2-alkanediol) as an active ingredient. That is, the composition of the present invention may be a quasi-drug composition requiring antibacterial activity.
본 발명의 조성물을 첨가물로 사용할 경우, 상기 조성물을 그대로 첨가하거나 다른 의약외품 또는 의약외품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 사용목적에 따라 적합하게 결정될 수 있다. When the composition of the present invention is used as an additive, the composition may be added as it is or may be used together with other quasi-drugs or quasi-drugs, and may be appropriately used according to a conventional method. The mixing amount of the active ingredient can be appropriately determined depending on the purpose of use.
바람직하게는, 상기 의약외품 조성물은 소독청결제, 샤워폼, 가그린, 물티슈, 세제비누, 핸드워시, 가습기 충진제, 마스크, 연고제, 코팅제 또는 필터충진제일 수 있다.
Preferably, the quasi-drug composition may be a disinfectant cleaner, shower foam, gagrin, a wet tissue, a detergent soap, a hand wash, a humidifier filler, a mask, an ointment agent, a coating agent or a filter filler.
또 하나의 양태로서, 본 발명은 옥틸 갈레이트 및 보존제(1,2-알칸 다이올)을 유효 성분으로 함유하는 약학적 조성물을 제공할 수 있다. 본 발명의 조성물은 항균 활성을 갖는 약학적 조성물일 수 있으며 의약 용도를 갖는 유효 성분의 보조제로써 사용할 수 있다. 본 발명의 약학적 조성물은 기술분야의 당업자라면 잘 알고 있는 방법에 따라 제조될 수 있다. In another embodiment, the present invention can provide a pharmaceutical composition containing octyl gallate and a preservative (1,2-alkanediol) as an active ingredient. The composition of the present invention may be a pharmaceutical composition having antimicrobial activity and may be used as an adjuvant of an active ingredient having medicinal use. The pharmaceutical compositions of the present invention may be prepared according to methods well known to those skilled in the art.
본 발명의 약학적 조성물은 통상의 방법에 따라 정제, 환제, 산제 과립제, 캡슐제, 현탁제, 내용액제, 유제 또는 시럽제의 경구형 제형, 외용제, 좌제 또는 주사용액의 형태로 제형화하여 사용할 수 있다. 상세하게는 제형화할 경우, 통상 사용하는 충진제, 중량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제될 수 있다. 경구투여를 위한 고형제제로는 정제, 환제, 산제, 과립제, 캡슐제 등을 포함하나, 이에 한정되는 것은 아니다. 이러한 고형제제는 상기 옥틸 갈레이트 및 상승작용 목적 혼합물을 포함하는 조성물 외에 적어도 하나 이상의 부형제, 예를 들면, 전분, 칼슘 카보네이트, 수크로오스, 락토오스, 젤라틴 등을 섞어 조제될 수 있다. The pharmaceutical composition of the present invention may be formulated in the form of tablets, pills, powders, capsules, suspensions, oral solutions, emulsions or syrups, oral preparations, suppositories or injection solutions according to a conventional method have. In detail, when formulated, it can be prepared by using diluents or excipients such as fillers, weighing agents, binders, wetting agents, disintegrants, surfactants and the like which are generally used. Solid formulations for oral administration include, but are not limited to, tablets, pills, powders, granules, capsules, and the like. Such a solid preparation may be prepared by mixing at least one excipient such as starch, calcium carbonate, sucrose, lactose, gelatin and the like in addition to the composition comprising the octyl gallate and the synergistic target mixture.
또한, 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용될 수 있다. 경구를 위한 액상물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등을 첨가하여 조제될 수 있다. 비경구 투여를 위한 제제는 멸균된 수용액, 비수성 용제, 현탁제, 유제, 동결건조 제제 및 좌제를 포함할 수 있다. 비수성 용제 및 현탁제로는 프로필렌글리콜, 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 오일, 에틸올레이트와 같은 주사가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔, 마크로골, 트윈 61, 카카오지, 라우린지, 글리세로젤라틴 등이 사용될 수 있다.In addition to simple excipients, lubricants such as magnesium stearate and talc may also be used. Liquid preparations for oral administration, liquid paraffin, and various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like. Formulations for parenteral administration may include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, lyophilized preparations and suppositories. Non-aqueous solvents and suspensions may include propylene glycol, polyethylene glycol, vegetable oils such as olive oil, injectable esters such as ethyl oleate, and the like. Examples of the suppository base include withexol, macrogol, tween 61, cacao butter, laurin, glycerogelatin and the like.
본 발명의 조성물은 목적하는 방법에 따라 경구 투여하거나 비경구투여(예를들어, 정맥 내, 피하, 복강 내 또는 국소에 적용)할 수 있으며, 투여량은 환자의 상태 및 체중, 질병의 정도, 약물형태, 투여경로 및 시간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다.
The composition of the present invention may be administered orally or parenterally (for example, intravenously, subcutaneously, intraperitoneally or topically) depending on the desired method, and the dose may be determined depending on the condition and weight of the patient, The mode of administration, the route of administration, and the time, but may be suitably selected by those skilled in the art.
또 하나의 양태로서, 본 발명은 옥틸 갈레이트 및 보존제(1,2-알칸 다이올)을 유효 성분으로 함유하는 항균용 조성물을 제공할 수 있다. 본 발명의 조성물은 항균용 조성물일 수 있으며, 상기 항균용 조성물은 기술분야의 당업자라면 잘 알고 있는 방법에 따라 제조될 수 있다.
In another aspect, the present invention can provide an antimicrobial composition containing octyl gallate and a preservative (1,2-alkanediol) as an active ingredient. The composition of the present invention may be an antimicrobial composition, and the antimicrobial composition may be prepared by a method well known to those skilled in the art.
또 하나의 양태로서, 본 발명은 옥틸 갈레이트 및 보존제(1,2-알칸 다이올)을 유효 성분으로 함유하는 방부제 조성물을 제공할 수 있다. 본 발명의 조성물은 유효성분으로 포함하는 방부제 조성물일 수 있으며, 상기 방부제 조성물은 기술분야의 당업자라면 잘 알고 있는 방법에 따라 제조될 수 있다.In another aspect, the present invention can provide a preservative composition containing octyl gallate and a preservative (1,2-alkanediol) as an active ingredient. The composition of the present invention may be an antiseptic composition comprising as an active ingredient, and the preservative composition may be prepared according to a method well known to those skilled in the art.
본 발명에 따른 방부제 조성물은 방부제 조성물이 함유되는 제품의 종류 및 사용목적에 따라 통상 사용하는 성분의 적당량을 배합하여 사용할 수 있다. 예를 들어, 초산, 초산나트륨계, 소르빈산계, 안식향산계, 프로피온산계를 추가할 수 있으며, 천연 Linseed Oil 비누, 봉랍 비누, 아카시아 수액 등 천연유화제로 유화를 시켜 수용성과 유성유화제로 제조하여 액상, 분말 등 자유자재로 제조 공급할 수 있다.
The preservative composition according to the present invention may be used in combination with an appropriate amount of commonly used components depending on the kind of the product containing the preservative composition and the intended use. For example, it is possible to add acetic acid, sodium acetate, sorbic acid, benzoic acid and propionic acid. It is emulsified with natural emulsifier such as natural linseed oil soap, propolis soap and acacia sap, Powder, etc. can be freely manufactured and supplied.
본 발명에 따른 옥틸 갈레이트를 항균 상승 효과의 목적으로 사용하여 다양한 균들에 대한 폭넓은 항균활성 스펙트럼을 나타낼 수 있으므로 이를 포함하는 조성물은 화장품, 의약, 생활용품, 농약 등 다양한 분야에서 살균, 항균, 방부목적으로 유용하게 이용가능하다.
Since the octyl gallate according to the present invention can be used for the purpose of enhancing the antimicrobial activity, it can exhibit a broad spectrum of antimicrobial activity against various fungi. Therefore, the composition containing the same can be used as a sterilizing, antibacterial and antifungal agent in various fields such as cosmetics, medicines, It is useful for preservation purposes.
이하, 하기 실시예를 통하여 본 발명을 더욱 상세하게 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.
Hereinafter, the present invention will be described in more detail with reference to the following examples. These embodiments are only for illustrating the present invention, and the scope of the present invention is not construed as being limited by these embodiments.
실시예Example
1. One.
옥틸 Octyl
갈Go
레이트Rate
와 기존 보존제 혼합물의 보존성 측정And preservation of existing preservative mixtures
옥틸 갈레이트를 기존 보존제과 혼합시켜 보존성의 상승 효과 여부를 확인하였다. 보존성의 시험은 유럽 약전에 따라서 측정하였다. 간략히 설명하면, 미생물의 정상 접종 후 조제물의 오염도(최종 비율), 특정 온도에서의 접종 조제물의 보존, 특정 시간 간격을 두고 용기로부터 시료를 채취하고 채취한 시료 중에서 미생물 수를 측정하였다. 실시 조건하의 정상 온도 조건에 있어 접종 조제물의 미생물 수가 유의미하게 감소되거나, 유지될 때에는 보존성은 적당하다고 보았다. 측정 실험법의 자세한 사항은 유럽 약전(ISBN 3-7692-2768-9;제3판의 2001, 제5.1.3장의 페이지 421~422)과 동일하였다.
Octyl gallate was mixed with conventional preservatives to confirm the synergistic effect of preservability. Conservative testing was performed according to the European Pharmacopoeia. Briefly, the contamination degree (final ratio) of the preparation after the normal inoculation of the microorganisms, the preservation of the inoculated preparation at a specific temperature, and the number of microorganisms were measured in the sample collected from the container at specific time intervals. The storage stability was considered adequate when the microbial count of the inoculum was significantly reduced or maintained under normal temperature conditions under the operating conditions. The details of the method of measurement were the same as in the European Pharmacopoeia (ISBN 3-7692-2768-9; 3rd ed. 2001, Chapter 5.1.3, pages 421-422).
1-1. 사용 미생물 및 최초 농도1-1. Use microorganism and initial concentration
보존성 측정을 위하여 하기 미생물을 이용하였다.The following microorganisms were used for storage stability.
A:대장균 ATCC 8739 A: E. coli ATCC 8739
B:녹농균 ATCC 9027 B: Pseudomonas aeruginosa ATCC 9027
C:황색 포도상구균 ATCC 6538 C: Staphylococcus aureus ATCC 6538
D:흰색 칸디다 ATCC 10231 D: white Candida ATCC 10231
E:흑색 아스퍼질러스 ATCC 16404 E: Black Aspergillus ATCC 16404
여러 가지 실험에 대하여 상기 미생물들은 최초의 미생물 수(CFU/g; "0"값)은 240, 000~300, 000의 범위 내로 처리하였다.
For various experiments, the microorganisms were treated with an initial number of microorganisms (CFU / g; "0" value) within the range of 240, 000-300,000.
1-2. 1-2. 조제물Preparation 제조 Produce
보존성 측정을 위해서 (a) 상승작용을 측정할 항균 활성 혼합물과 (b) 대조군으로 대응하는 비혼합 1,2-AlkaneDiol을 제조하였다.For the preservability measurement, (a) an antimicrobial active mixture to measure synergism and (b) a corresponding unmixed 1,2-AlkaneDiol as a control group were prepared.
제조한 조제물의 조합은 하기 표 1의 조성을 가졌다.The combinations of the preparations thus prepared had the composition shown in Table 1 below.
1-3. 보존성 실험1-3. Conservation experiment
상기 제조한 에멀젼의 보존성을 측정하기 위해서, 해당 에멀젼에 아스퍼질러스를 접종한 후 14일의 배양하여 미생물의 수를 측정하였다. 대조군으로 옥틸 갈레이트와 1,2-헥산다이올을 혼합시키지 않고 각각을 단독으로 포함하는 동일한 조성의 에멀젼을 제조하여 동일한 실험을 진행하였다. 상기 실험에 따른 옥틸 갈레이트와 1,2-헥산다이올의 상승작용성 계수(SI)를 측정하였으며, 결과는 하기 표 2와 같다. In order to measure the preservability of the prepared emulsion, Aspergillus was inoculated in the emulsion, and the microorganisms were counted by culturing for 14 days. As the control group, emulsions of the same composition containing octyl gallate and 1,2-hexanediol were separately prepared without mixing them, and the same experiment was carried out. The synergistic coefficient (SI) of octyl gallate and 1,2-hexanediol according to the above test was measured. The results are shown in Table 2 below.
(옥틸 갈레이트 포함)Emulsion 1
(Including octyl gallate)
(1,2-헥산다이올 포함)Emulsion 2
(Including 1,2-hexanediol)
(옥틸 갈레이트 및 1,2-헥산다이올 1:2 혼합 포함)Emulsion 3
(Including 1: 2 mixture of octyl gallate and 1,2-hexanediol)
(CFU/g)Aspergillus Day 14
(CFU / g)
상승성 수치를 구하는 공식(Kull equation)은 다음과 같다.The Kull equation for ascertaining numerical values is as follows.
SI = C x D / A + C x E / BSI = C x D / A + C x E / B
본 발명에 따른 디올 혼합물의 활성의 상승작용 목표 증강은 상기 Kull 등식 (F.C.Kull et al., ;Applied Microbiology Vol.9, p.538-541(1961);David C.Steinberg;Cosmetics & Toiletries Vol.115(No.11), p.59-62;November 2000)에 근거해 나타내 보였다. Kull의 등식은 순수 물질과 그것들로부터 조제된 활성화합물 혼합물을 그러한 항균 활성에 대한 비교를 가능하게 한다. 이 등식에 의해, 항균작용을 가지는 혼합물의 상승작용 목표 활성, 그러나 또 가능한 길항작용의 지표인, 이른바 상승작용성 계수(SI)가 결정된다. 상승효과는, 결정되는 SI치가 1 미만인 경우에 명료하다. 한편, 정확하게 1의 SI가 계산되는 경우에는, 항균작용을 가지는 2종의 물질의 순수한 더하기 효과가 존재한다. 한편, 1을 넘는 SI치의 경우에는, 길항작용 효과가 존재한다.
The synergistic target enhancement of the activity of the diol mixture according to the present invention is described in the Kull equation (FCKull et al., Applied Microbiology Vol. 9, p. 538-541 (1961); David C. Steinberg; Cosmetics & Toiletries Vol.115 (No.11), p. 59-62; November 2000). The Kull's equation makes it possible to compare pure materials and mixtures of active compounds prepared therefrom against such antimicrobial activity. This equation determines the synergistic target activity of a mixture having an antibacterial action, but also the so-called synergistic coefficient SI, which is an index of possible antagonistic action. The synergistic effect is clear when the determined SI value is less than 1. On the other hand, when an SI of exactly one is calculated, there exists a pure addition effect of two kinds of substances having antibacterial action. On the other hand, in the case of an SI value exceeding 1, an antagonistic effect exists.
1-4. 보존성 실험 결과1-4. Conservation test result
상기 보존성 실험의 결과 정상 질량비의 옥틸 갈레이트와의 혼합물은 동일 농도로 계량된 개개의 물질보다 훨씬 큰 활성을 가지는 것이 밝혀졌다. 이것은 특히, 14일 및 28일 후 잔류한 잔류 미생물 수에 대해서 나타났다. As a result of the preservation experiment, it was found that the mixture of octyl gallate with the normal mass ratio had much greater activity than the individual substances measured at the same concentration. This was especially noted for residual microbial counts remaining after 14 and 28 days.
상기 표 2의 결과는 14일의 배양 후의 옥틸 갈레이트와 1,2-헥산다이올과의 혼합물(비율 1:2)에 의한 아스퍼질러스의 처리에 대한 SI치의 계산을 나타낸다. 0.11의 계산 SI는 옥틸 갈레이트와 1,2-헥산다이올의 1:2 혼합물이 활성화합물의 현저하고 상승작용적인 조합 물건인 것을 명백하게 나타내 보이고 있다. The results in Table 2 above show the calculation of the SI value for the treatment of aspergillus with a mixture of octyl gallate and 1,2-hexanediol (ratio 1: 2) after 14 days of culture. The calculated SI of 0.11 clearly shows that a 1: 2 mixture of octyl gallate and 1,2-hexanediol is a prominent synergistic combination of active compounds.
1,2-펜탄다이올, 1,2-헥산다이올 및/혹은1,2-옥탄다이올과의 옥틸 갈레이트 2종 및 3종 혼합물은 여기서 특히 유효인 것이 판명되었다. 모든 5종의 시험 미생물(대장균, 녹농균, 황색 포도상구균, 칸디다 및 아스퍼질러스)의 사례에 대하여, 28일 후에는 바람직한 목표의 0치까지 집락형성단위(CFU)의 농도로 감소시킬 수 있었다. 즉, 상기 혼합물을 사용했을 때 이 인큐베이트 상 후에 미생물 수는 0이었으므로, 28-일의 SI치를 결정할 수 없었다(표 3 참조). 따라서, 이 구체적인 예에서는 Kull 등식을 사용할 수 없지만, 상승작용성은 0의 미생물 수에 근거해 명백하였다.A mixture of two and three octyl gallates with 1,2-pentanediol, 1,2-hexanediol and / or 1,2-octanediol has proven to be particularly effective here. For all of the 5 tested microorganisms (E. coli, P. aeruginosa, S. staphylococci, Candida and Aspergillus), after 28 days, the concentration of the colony forming units (CFU) could be reduced to zero of the desired target. That is, when the mixture was used, the number of microorganisms after the incubation phase was 0, so the SI value of 28-days could not be determined (see Table 3). Therefore, although the Kull equation can not be used in this specific example, synergism is apparent based on the number of microorganisms of zero.
상기 표 2 및 28일간의 기간에 걸치는 아스퍼질러스에 대한 적절한 보존성의 시험, 옥틸 갈레이트(O/W 에멀젼 중 3%), 1,2-헥산다이올(O/W 에멀젼 중 3%), Octyl galalte/1,2-헥산다이올 혼합물(질량비 2:1, 용량은 같이 3%)에 대한 미생물 수의 감소의 대수 곡선에서 확인할 수 있듯이, 산업 제품의 보존성에 관해서 특히 문제를 일으키는 미생물의 아스퍼질러스의 경우에는, 본 발명에 따른 혼합물을 사용하는 경우 28일 이내에 미생물 수(단위 : 집락형성단위 수, CFU)를 0까지 감소시킬 수 있었다. 한편, 대조의 목적으로 시험된, 똑같이 3%의 용량의 각각 단독의 물질(옥틸 갈레이트, 1,2-프로판다이올, 1,2-펜탄다이올, 1,2-헥산다이올, 1,2-옥탄다이올 및 1,2-데케인다이올)은 혼합물이 보이는 미생물 감소치인 0까지는 감소시킬 수 없었다. 따라서, 시험 계열 및 표 3에 의해, 옥틸 갈레이트에 1,2-펜탄다이올, 1,2-헥산다이올, 1,2-옥탄다이올 및 1,2-데케인다이올로부터 완성되는 군의 적어도 2종의 다른 구성으로부터 완성되는 옥틸 갈레이트와 1,2-알칸 다이올 혼합물은 상승작용적으로 증가된 활성을 가지는 것을 나타낸다.
(3% in an O / W emulsion), 1,2-hexanediol (3% in an O / W emulsion), and a mixture of octyl gallate As can be seen in the logarithm of the decrease in the number of microorganisms for the octyl galalte / 1,2-hexanediol mixture (mass ratio 2: 1, volume is 3%), In the case of the parasites, the number of microorganisms (number of colony forming unit, CFU) could be reduced to 0 within 28 days when the mixture according to the present invention was used. On the other hand, the same 3% capacity of each substance (octyl gallate, 1,2-propanediol, 1,2-pentanediol, 1,2-hexanediol, 2-octanediol and 1, 2-decane diol) could not be reduced to zero, the microbial reduction of the mixture. Thus, according to the test series and Table 3, it was confirmed that octyl gallate was composed of 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol and 1,2- The octyl gallate and the 1,2-alkanediol mixture, which are composed of at least two different constituents, have synergistically increased activity.
실시예Example
2. 각종 미생물에 대한 최소 저해 농도의 결정 및 2. Determination of the minimum inhibitory concentration for various microorganisms and
MICMIC
치에 근거하는 Chi-based
상승성 수치의 계산Calculation of ascendant values
본 발명에 따른 옥틸 갈레이트와 헥산다이올 혼합물이 체취의 원인이 되는 각종 미생물의 억제에 효과를 가지는지 확인하였다. 특히, 체취와 관련된 표피 포도상구균, 코리네박테리움 키세로시스 및 표피 브레비박테리움에 대하여 최소 저해 농도를 측정하여 혼합물에 의한 상승성 수치를 상기와 같은 공식을 이용하여 측정하였다. It was confirmed that the mixture of octyl gallate and hexane diol according to the present invention had an effect on the inhibition of various microorganisms causing body odor. Particularly, the minimum inhibitory concentration was measured for Staphylococcus epidermidis, Corynebacterium crispycis, and Epidermis Brevibacterium in relation to body odor and the ascendant value by the mixture was measured using the above formula.
구체적으로는 본 발명에 따른 옥틸 갈레이트 및 1,2-헥산다이올 혼합물의 항균작용을 DIN 58 940/ICS 및 DIN 58 944/ICS에 근거한 한천 희석법을 통해 측정하였다. 직경 9.0 cm의 샬레에 50℃으로 액체 상태로 유지된, 13.5 ml의 조제한 지 얼마 안되는 물러힌톤(Mueller-Hinton) 한천(Merck, Ref.1.054437 혹은 윌킨스찰그렌(Wilkins-Chalgren) 한천 육즙, Oxoid, Ref.CM 643, 10 g의 한천/1리터를 보충)에 여러 가지 농도의 희석 시료를 10%(V/V) = 1.5 ml로 첨가했다. 시험 미생물의 마라세지아 풀 풀(Malassezia furfur)에 대해서는, 3% 트윈80(Merck, Ref.8.22 187)을 함유하는 물러힌톤(Mueller-Hinton) 한천을 사용하였다.Specifically, the antimicrobial activity of a mixture of octyl gallate and 1,2-hexanediol according to the present invention was measured by an agar dilution method based on DIN 58 940 / ICS and DIN 58 944 / ICS. 13.5 ml of the prepared Mueller-Hinton agar (Merck, Ref. 1. 054437 or Wilkins-Chalgren agar juice, Oxoid, Ref. CM 643, supplemented with 10 g of agar / 1 liter), diluted samples of various concentrations were added at 10% (V / V) = 1.5 ml. For the test microbial Malassezia furfur, a Mueller-Hinton agar containing 3% Tween 80 (Merck, Ref.8.22 187) was used.
각 예에 대하여, 5 ml의 시료를 증류수에 희석해 10 ml에 조제했다. 기하학 목표 계열의 형태로 조제된 상위 시험 농도의 구체적인 희석 계열을, 이 배치의 증류수에 의한 점진적 1:1 희석에 의해 조제했다.For each example, 5 ml of sample was diluted with distilled water to prepare 10 ml. A specific dilution series of the upper test concentration prepared in the form of a geometric target sequence was prepared by gradual 1: 1 dilution of this batch with distilled water.
시험 한천(1.5 ml의 시료 혹은 대응하는 희석물 + 13.5 ml의 한천)에 의한 희석에 의해 각 예에 대해 10배 희석된 최종 농도를 달성했다(각각 첫 회 농도가 50, 000 ppm에 달한다). 1종의 시험 농도 및 영양소 배지 당 2개의 한천 플레이트가 주입되었다. 각 예에 대해 2개의 한천 플레이트에 의해 이하의 대조 시험을 실시했으며, 실험 조건은 하기 표 3과 같다.
A final concentration of 10-fold diluted for each sample was achieved by dilution with the test agar (1.5 ml of sample or corresponding dilution + 13.5 ml of agar) (each concentration reaching 50,000 ppm for the first time). Two agar plates per one test concentration and nutrient medium were injected. The following control tests were carried out on two agar plates for each example, and the experimental conditions are shown in Table 3 below.
고체화 및 마른 후(37℃으로 약 1시간), 시험 플레이트를 각 예에 대하여, 아래 표의 시험 미생물 현탁액 1μl에 의해 점형태로 접종했다. 순도를 교정해, 분류하기 위해서 호기에 생장 하는 박테리아(브레비박테륨 에피더미스, 코리네박테리움 키세로시스, 스파필로코커스 에피더미스)를 Columbia 혈액한천배지(BioMerieux, Ref.430049) 위에서 배양했다. 곰팡이의 흑색 아스퍼질러스, 효모균의 흰색 칸디다 및 2종의 피부 진균류의 트리코피톤 멘타그로피테스 및 에피데르모피톤 후로코슴을 Sabouraud 한천(BioMerieux, Ref.43555) 위에서 배양했다. 마라세지아 풀풀을 탈 억제제(3% 트윈 80:1%; 레시틴:0.3%; 히스티딘:0.1%; Merck, Ref.1.18368의 첨가)를 포함한 Sabourad HLT 한천 위에서 배양했다. 프로피오니박테리움 아크네스를 Schaedler 한천(BioMerieux, Ref.43273) 위에서 배양했다. 시험 미생물의 한층 더 자세한 것은 하기 표 5에 정리하였다.After solidification and drying (about 1 hour at 37 占 폚), the test plates were inoculated in dotted form with 1 占 of the test microbial suspension in the table below for each sample. Bacteria (Brevibacterium epidermis, Corynebacterium kiocellisis, Spilophyllococus epidermis) growing on aerials to calibrate and classify purity were cultured on Columbia blood agar medium (BioMerieux, Ref. 430049) did. Fungal black aspergillus, yeast white candida, and two types of skin fungus, tricophyton menthylphosphate and epidermophytonthrophococcus, were cultured on Sabouraud agar (BioMerieux, Ref. 43555). Marassezia fructus was cultured on a Sabourad HLT agar containing a depressor inhibitor (3% Tween 80: 1%; lecithin: 0.3%; histidine: 0.1%; Merck, Ref.1.18368 supplemented). Propionibacterium acnes were cultured on Schaedler agar (BioMerieux, Ref.43273). Further details of the test microorganisms are summarized in Table 5 below.
호기에 생장하는 박테리아 미생물의 시험 세균 현탁물의 조제는 36℃로 관련 시험균의 몇개의 개개의 콜로니를 접종 된 물러힌톤(Mueller-Hinton) broth(Merck, Ref.1.10293)의 인큐베이트에 의해 실시했다. 명백한 혼탁을 얻은 후에, 멸균 영양소 broth를 그 혼탁도가 맥파랜드(McFarland) 표준 0.5( 약 1.5×108CFU/ml)에 상당하는 양으로 현탁액에 첨가했다.
Test of bacterial microorganisms growing on aerials The preparation of bacterial suspensions was carried out by incubating several individual colonies of the relevant test organisms at 36 ° C with an inoculated Mueller-Hinton broth (Merck, Ref. 1.10293) . After obtaining clear turbidity, the sterile nutrient broth was added to the suspension in an amount corresponding to the turbidity of McFarland standard 0.5 (about 1.5 x 108 CFU / ml).
다른 시험균 현탁액의 조제에 대해서는, 시험주를 상기의 고체 영양소 배지 위에서 배양해, 멸균 면봉을 사용해 수확해, 현탁액의 혼탁도가 맥파랜드(McFarland) 표준 0.5에 상당하는 물러힌톤(Mueller-Hinton) borth에 희석했다.
For the preparation of other test strain suspensions, the test strains were cultivated on the above-mentioned solid nutrient medium and harvested using a sterile swab, the turbidity of the suspension was measured using a Mueller-Hinton equivalent to McFarland standard 0.5, borth diluted.
프로피오니박테리움 아크네스를 제외하는 모든 시험균 현탁액을 멸균 broth로 재차 1:10에 희석해, 그 균 수를 스피랄메터(Spiralometer)를 사용하는 표면법에 의해 측정했다.All suspensions of the test bacteria except Propionibacterium acnes were diluted 1:10 with sterile broth again and the number of bacteria was measured by a surface method using a spiral meter.
접종된 플레이트를 하기 표 6에 나타낸 조건하에서 배양하여 평가했다. MIC(최소 저해 농도)는, 현미경적으로 생장을 볼 수 없는 활성화합물의 최저농도라고 보았다. 크기가 작아 거의 인정할 수 없는 생장 혹은 작은 개개의 콜로니를 보이는 경우에는 저해 농도라고 평가했다.The inoculated plates were cultured under the conditions shown in Table 6 below and evaluated. The MIC (minimum inhibitory concentration) was considered to be the lowest concentration of active compound that could not be observed microscopically. It was evaluated as inhibitory concentration when growth was small or small individual colonies were seen because they were small in size.
3% 트윈 80Mueller-Hinton agar +
3% twin 80
상기 조건에 따른 실험의 결과에 대하여, 옥틸 갈레이트, 1,2-헥산다이올, 및 옥틸 갈레이트/1,2-헥산다이올 = 2:1의 2종의 혼합물의 MIC치를 일반적 방법에 따라서 측정하였다. 그 결과는 하기 표 7과 같다.
The MIC values of the mixture of octyl gallate, 1,2-hexanediol, and octyl gallate / 1,2-hexanediol = 2: 1 were determined according to the general method, Respectively. The results are shown in Table 7 below.
상기 표 7에 나타낸 결과에 의해, 옥틸 갈레이트 및 1,2-헥산다이올에 대해서, 2종의 2:1 혼합물이 항균 활성의 상승 효과를 나타내고 있다. 따라서, 스타필로코커스 에피더미스, 브레비박테륨 에피더미스, 코리네박테리움 키세로시스, 프로피오니박테리움 아크네스, 트리코피톤 멘타그로피테스 및 에피데르모피톤 후로코슴과 같은 미생물은 대응하는 개개의 물질과 직접 비교하면, 옥틸 갈레이트 및 1,2-헥산다이올 혼합물에 의해 명확하게 활성이 억제된다. According to the results shown in Table 7, two kinds of 2: 1 mixture of octyl gallate and 1,2-hexanediol exhibit a synergistic effect of antimicrobial activity. Therefore, microorganisms such as Staphylococcus epidermis, Brevibacterium epidermis, Corynebacterium kyciatus, Propionibacterium acnes, Tricophyton mentagrophytes, and Epidermophyton furocotes correspond. The activity is clearly inhibited by a mixture of octyl gallate and 1,2-hexanediol.
MIC치에 근거하여 쿨(Kull) 등식을 통해 계산된 상승작용성 계수도 상기 표 7에 나타내었다. SI치는 옥틸 갈레이트/1,2-헥산다이올의 혼합물이 상승작용적으로 증강된 작용을 가져, 보존제로서의 그 뛰어난 활성에 가세해(실시예 1 참조) 더욱 바람직하게는, 체취의 억제에(SI 스타필로코커스 에피더미스: 0.55; SI 코리네박테리움 키세로시스 : 0.66 ; SI 브레비박테륨 에피더미스: 0.83), 여드름의 억제에(SI 프로피오니박테리움 아크네스:0.25) 그리고 트리코피톤 및 에피데르모피톤종에 의해 일으켜지는 피부 및 진균증의 억제에(SI 트리코피톤 멘타그로피테스: 0.49; SI 에피데르모피톤 후로코슴:0.32) 사용할 수 있는 것을 명백하게 나타내 보이고 있다. 다만, 마라세지아 풀풀에 대해서는, 옥틸 갈레이트/1,2-헥산다이올 혼합물에 대한 상승작용 목표 효과를 나타내지 않았다(SI마라세지아 풀풀: 2.97, 즉 길항작용 효과).
The synergistic coefficients calculated through the Kull equation based on the MIC values are also shown in Table 7 above. The SI value has a synergistically enhanced action of a mixture of octyl gallate / 1,2-hexanediol and added to its excellent activity as a preservative (see Example 1). More preferably, SI propionibacterium epidermis: 0.55; SI cornea bacterium keratosis: 0.66; SI bributibacterium epidermis: 0.83), inhibition of acne (SI propionibacterium acnes: 0.25) and tricophytonthin (SI tricophyton mentagrophytes: 0.49; SI epidermophytone furocotes: 0.32) can be used to inhibit skin and mycosis caused by epidermidis and epidermophyton. However, for Marasegia frumula, it did not show the synergistic target effect on the mixture of octyl gallate / 1,2-hexanediol (SI Marasegia frumula: 2.97, that is, antagonistic effect).
실시예Example
3. 3.
옥틸 Octyl
갈Go
레이트Rate
혼합물과 추가 보존제 혼합에 의한 보존성 측정 Conservation test by mixture and additional preservative mixture
옥틸 갈레이트의 상승작용 목표 혼합물(a)과 추가 보존제(b)의 혼합물에 의한 보존성을 유럽 약국방에 따라서 실시예 1과 동일한 방법으로 측정하였다.
Synergism of octyl gallate The preservability of the mixture of the target mixture (a) and the additional preservative (b) was measured in the same manner as in Example 1 according to European Pharmacopoeia.
3-1. 사용 미생물 및 최초 농도3-1. Use microorganism and initial concentration
보존성 측정을 위하여 하기 미생물을 이용하였다.The following microorganisms were used for storage stability.
A:대장균 ATCC 8739 A: E. coli ATCC 8739
B:녹농균 ATCC 9027 B: Pseudomonas aeruginosa ATCC 9027
C:황색 포도상구균 ATCC 6538 C: Staphylococcus aureus ATCC 6538
D:흰색 칸디다 ATCC 10231 D: white Candida ATCC 10231
E:흑색 아스퍼질러스 ATCC 16404 E: Black Aspergillus ATCC 16404
여러 가지 실험에 대하여 상기 미생물들은 최초의 미생물 수(CFU/g; "0"값)은 280, 000~320, 000의 범위 내로 처리하였다.
For various experiments, the microorganisms were treated with a range of initial microorganisms (CFU / g; "0" value) in the range of 280, 000 to 320, 000.
3-2. 3-2. 조제물Preparation 제조 Produce
보존성 측정을 위해서 본 발명에 따른 옥틸 갈레이트 혼합물(a) 및 추가 보존제(b)를 포함하는 상승작용 후보 조합 혼합물을 함유하는 에멀전을 제조하였다. 비교를 위하여 대조군으로 상기 옥틸 갈레이트 혼합물(a) 및 추가 보존제(b)를 각각 단독으로 포함하는 에멀전을 제조하였다.For the preservability measurement, an emulsion containing the synergistic candidate combination mixture comprising the octyl gallate mixture (a) according to the invention and the additional preservative (b) was prepared. For comparison, an emulsion comprising the octyl gallate mixture (a) and the additional preservative (b) alone as a control group was prepared.
상기 제조한 조제물의 조합은 하기 표 8의 조성을 가졌다.The combinations of the preparations prepared above had the composition shown in Table 8 below.
0.1% Euxyl K400Emulsion A
0.1% Euxyl K400
0.5% 옥틸 갈레이트, 0.5% 1,2-헥산다이올Emulsion B
0.5% octyl gallate, 0.5% 1,2-hexanediol
0.05% Euxyl K400, 0.25% 옥틸 갈레이트, 0.25% 헥산다이올Emulsion C
0.05% Euxyl K400, 0.25% octyl gallate, 0.25% hexane diol
상기 표 8에서는, 0.05%의 Euxyl K400(1,2-디브로모2,4-디시아노부탄(20%) 및 2-페녹시 에탄올(80%)의 혼합물), 0.25%의 옥틸 갈레이트 및 0.25%의 1,2-헥산다이올로부터 완성되는 본 발명에 따른 혼합물에 대한 에멀젼 조제물을 예로서 나타내었다. 에멀젼 안의 옥틸 갈레이트 혼합물 및 추가 보존제 Euxyl K400의 총 농도의 변화는, 동일 조제물이 항상 총계로 100 중량부를 포함해서 완성되도록 수분 함량을 증가 혹은 감소시키는 것으로 보정되었다
In Table 8 above, a mixture of 0.05% Euxyl K400 (mixture of 1,2-dibromo 2,4-dicyanobutane (20%) and 2-phenoxyethanol (80%)), 0.25% An emulsion preparation for a mixture according to the invention consisting of 0.25% of 1,2-hexanediol is given as an example. The change in the total concentration of the octyl gallate mixture in the emulsion and the additional preservative Euxyl K400 was corrected by increasing or decreasing the moisture content so that the same preparation always contained 100 parts by weight in total
3-3. 보존성 실험3-3. Conservation experiment
상기 제조한 에멀젼의 보존성을 측정하기 위해서, 해당 에멀젼에 아스퍼질러스를 접종한 후 28일간 배양하여 잔류한 흑색 아스퍼질러스 미생물 수를 측정하였다. 즉, 본 발명에 따른 옥틸 갈레이트/1,2-헥산다이올 혼합물과 추가 보존제의 상승작용을 확인하기 위하여, 각각을 단독으로 포함하는 동일한 조성의 에멀젼과 Octyl gallte/1,2-헥산다이올/EuxylK400을 포함하는 에멀젼에 대하여 보존성 부하실험을 진행하였다(표 9). In order to measure the preservability of the prepared emulsion, Aspergillus was inoculated into the emulsion and cultured for 28 days to determine the number of remaining black aspergillus microorganisms. That is, in order to confirm the synergistic action of the octyl gallate / 1,2-hexanediol mixture and the additional preservative according to the present invention, emulsions of the same composition containing each alone and octyl gallte / 1,2- / EuxylK400 (Table 9). ≪ tb > < TABLE >
상기 실험에 따른 옥틸 갈레이트/1,2-헥산다이올 혼합물과 EuxylK400의 상승작용성 계수(SI)를 측정하였으며, 결과는 하기 표 10과 같다. The synergistic coefficient (SI) of the octyl gallate / 1,2-hexanediol mixture and Euxyl K400 according to the above experiment was measured. The results are shown in Table 10 below.
-옥틸 갈레이트 0.5% + 1,2 헥산다이올 0.5%Emulsion 1
- octyl gallate 0.5% + 1,2 hexanediol 0.5%
-Euxyl K400 0.1%Emulsion 2
-Euxyl K400 0.1%
-옥틸 갈레이트 0.25% + 1,2 헥산다이올 0.25% + Euxyl K400 0.05%Emulsion 3
- octyl gallate 0.25% + 1,2hexanediol 0.25% + Euxyl K400 0.05%
(CFU/g)Aspergillus 28th day
(CFU / g)
상승성 수치를 구하는 공식(Kull equation; SI = C x D / A + C x E / B)은 상기 실시예 1에서 설명한 바와 같다.
The formula for obtaining the ascendant value (SI = C x D / A + C x E / B) is as described in the first embodiment.
3-4. 보존성 실험 결과3-4. Conservation test result
상기 흑색 아스퍼질러스를 접종한 후 28일 후 잔류한 잔류 미생물 수를 측정한 보존성 실험 결과, 옥틸 갈레이트와 1,2-헥산다이올 혼합물 자체 뿐만 아니라 추가 보존제와의 혼합물도 동일 농도의 개개 물질과 비교하여 유의미한 활성의 상승 효과를 가지는 것이 발견되었다.As a result of the preservation test to measure the residual microorganisms remaining after 28 days from the inoculation of the black aspergillus, a mixture of octyl gallate and the 1,2-hexanediol mixture itself as well as the additional preservative was also added to each individual substance Lt; RTI ID = 0.0 > synergistic < / RTI > activity.
표 8에서 볼 수 있듯이, 산업 제품의 보존에 특히 문제가 되는 흑색 아스퍼질러스 미생물에 대하여, 에멀젼 C를 사용하는 것으로써 28일간 미생물 수를 2, 800 CFU/g까지 감소시킬 수 있었다. 한편, 1% 용량으로 실험된 에멀젼 A 및 0.1%의 용량으로 실험된 에멀젼 B는 아스퍼질러스 균에 대하여 에멀젼 C에 비하여 유의한 감소를 나타내지 않았다. As can be seen in Table 8, the use of Emulsion C for micro-aspergillus microorganisms, which is particularly problematic for the preservation of industrial products, could reduce microbial counts to 2,800 CFU / g over 28 days. On the other hand, emulsion A, which was tested at 1% capacity, and emulsion B, which was tested at a dose of 0.1%, showed no significant decrease compared to emulsion C for Aspergillus.
상기 결과는 (a) 옥틸 갈레이트에 1,2-프로판다이올, 1,2-펜탄다이올, 1,2-헥산다이올, 1,2-옥탄다이올 또는 1,2-데케인다이올을 추가하여 완성되는 군의 적어도 2 종의 다른 성분 및 (b) 추가 보존제를 포함하는 혼합물이 항균력 측면에서 상승작용성이 더욱 월등할 수 있음을 보여준다.
The results show that (a) octyl gallate can be treated with 1,2-propanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol or 1,2- , And (b) a mixture containing an additional preservative may be even more superior in terms of antimicrobial activity.
상기 표 10의 결과는 옥틸 갈레이트, 1,2-헥산다이올 및 EuxylK400을 포함하는 혼합물을 포함하는 에멀젼에 아스퍼질러스를 접종하고 28일간 배양기간 동안 또는 28일 배양 후의 미생물 수를 측정하여 항균력에 관한 SI 수치를 계산한 결과이다. SI 수치 0.066은 옥틸 갈레이트/1,2-헥산다이올 혼합물과 EuxylK400의 상승작용을 명백하게 나타내고 있다.
The results in Table 10 show that the number of microorganisms in the emulsion containing the mixture containing octyl gallate, 1,2-hexanediol and Euxyl K400 inoculated with Aspergillus and incubated for 28 days or for 28 days, The results of SI calculation are shown in Fig. The SI value 0.066 clearly indicates the synergistic action of the octyl gallate / 1,2-hexanediol mixture and EuxylK400.
상기 결과들을 종합하면, 본 발명에 따른 옥틸 갈레이트를 항균 상승 효과의 목적으로 사용하여 다양한 균들에 대한 폭넓은 항균활성 스펙트럼을 나타낼 수 있으므로 화장품, 의약, 생활용품, 농약 등 다양한 분야에서 살균, 항균, 방부목적으로 유용하게 이용가능한 것을 확인하였다.
The above results indicate that octyl gallate according to the present invention can be used for the purpose of enhancing the antibacterial activity to exhibit a broad spectrum of antimicrobial activity against various fungi. Therefore, sterilization, antibacterial and antimicrobial activities in various fields such as cosmetics, medicines, , And it can be useful for preservation purposes.
이상의 설명으로부터, 본 발명이 속하는 기술분야의 당업자는 본 발명이 그 기술적 사상이나 필수적 특징을 변경하지 않고서 다른 구체적인 형태로 실시될 수 있음을 이해할 수 있다. 이와 관련하여, 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 제한적인 것이 아닌 것으로 이해하여야 한다. 본 발명의 범위는 전술한 상세한 설명보다는 후술되는 특허 청구범위의 의미 및 범위, 그리고 그 등가 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.From the above description, it will be understood by those skilled in the art to which the present invention pertains that the present invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. In this regard, it should be understood that the above-described embodiments are illustrative in all aspects and not restrictive. The scope of the present invention should be construed as being included in the scope of the present invention, rather than the above detailed description, as well as all changes or modifications derived from the meaning and scope of the appended claims and their equivalents.
Claims (5)
An antimicrobial composition comprising a mixture of octyl gallate and a 1,2-alkanediol as an active ingredient.
The antimicrobial composition according to claim 1, wherein the octyl gallate is contained in an amount of 0.01 to 50% (w / v) based on the total weight of the composition.
The method of claim 1, wherein the 1,2-alkanediol is selected from the group consisting of 1,2-propanediol, 1,2-pentanediol, 1,2-hexanediol, - decane diol. ≪ RTI ID = 0.0 > 11. < / RTI >
The antimicrobial composition according to claim 1, wherein the preservative is further synergistically increased, wherein the preservative further comprises an additional preservative, wherein the additional preservative is selected from the group consisting of benzoic acid, its esters and salts, propionic acid and salts thereof, Salts thereof, 2,4-hexanoic acid (sorbic acid) and salts thereof, formaldehyde and paraformaldehyde, 2-hydroxybiphenyl ether and salts thereof, 2-zinc sulfide pyridine-N-oxide, (II) 5-amino-1,3-bis (2-hydroxy) benzoic acid, salts and esters thereof, dehydratcetic acid, formic acid , N-hexane and its salts, 1,6-bis (4-amidino-2-bromophenoxy) -n-hexane and its salts, sodium salt of ethyl mercury- (II) thiosalicylic acid, phenyl mercury and salts thereof, Amino-1,3-bis (2-ethylhexyl) -5-methyl-hexahydropyrimidine, 5-bromo-5-nitroso 1,3- 2-nitro-1,3-propanediol, 2,4-dichlorobenzyl alcohol, N- (4-chlorophenyl) -N '- (3,4-dichlorophenyl) Chloro-m-cresol, 2,4,4'-trichloro-2'-hydroxy-diphenyl ether, 4-chloro-3,5-dimethylphenol, 1,1'- (1-hydroxymethyl-2,4-deoxyimidazolidin-5-yl) urea) poly- (hexamethylene zigand) hydrochloric acid, 2-phenoxyethanol, hexamethylenetetramine, 1- -Chloroallyl) -3,5,7-triaza-1-azonia-adamantane-chloride, l- (4-chlorophenoxy) Dimethyl-2-butanone, 1,3-bis- (hydroxy-methyl) -5,5-dimethyl-2,4-imidazolidinedione, benzyl alcohol, Chloro-2-methylpyridine with 2,2'-methylene-bis (6-bromo-4-chloro-phenol), bromo-chlorophene, magnesium chloride and magnesium nitrate. -3 (2 H) -isothiazolinone and 2-methyl-3 (2 H) isothiazolinone , 2-benzyl-4-chlorophenol, 2-chloroacetamide, chlorohexidine, chlorohexidineacetate, chlorohexidine gluconate, chlorohexidine hydrochloride, 1-phenoxy- (C12-C22) trimethylammonium bromide and chloride, 4,4-dimethyl-1,3-oxazolidine, N-hydroxymethyl-N- (1,3- ) -2,5-dioxoimidazolidin-4-yl) -N'-hydroxy-methyl urea, 1,6-bis (4-amidinophenoxy) Aldehyde 5-ethyl-1-aza 3,7-dioxabicyclo (3.3.0) octane, 3- (4-croophenoxy) -1,2-propanediol, hyamine, C8-C18) -dimethyl-benzyl-ammonium chloride, alkyl- (C8-C18) -dimethyl- benzylammonium bromide, alkyl- Propyl-butylcarbamate, and sodium hydroxymethylaminoacetate. ≪ RTI ID = 0.0 > The stand will be selected at least one cosmetic composition.
The composition according to any one of claims 1 to 4, wherein the composition is used as a cosmetic composition, a pharmaceutical composition, a quasi-drug composition or an antiseptic composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130131769A KR102024947B1 (en) | 2013-10-31 | 2013-10-31 | Composition containing octyl gallate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130131769A KR102024947B1 (en) | 2013-10-31 | 2013-10-31 | Composition containing octyl gallate |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150050234A true KR20150050234A (en) | 2015-05-08 |
KR102024947B1 KR102024947B1 (en) | 2019-09-24 |
Family
ID=53388150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130131769A Active KR102024947B1 (en) | 2013-10-31 | 2013-10-31 | Composition containing octyl gallate |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102024947B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102059043B1 (en) | 2018-11-21 | 2019-12-24 | 주식회사 에이조스바이오 | Antiseptic Composition |
US10952956B2 (en) | 2016-06-27 | 2021-03-23 | Amorepacific Corporation | Antioxidant composition for skin |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110063359A (en) * | 2019-04-18 | 2019-07-30 | 浙江工商大学 | A kind of preparation method and application of biology crude antistaling agent |
KR20230101482A (en) | 2021-12-29 | 2023-07-06 | 주식회사 엑티브온 | A preservative for skin external application, and a cosmetic composition and a pharmaceutical composition comprising the same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR920021130A (en) * | 1991-05-27 | 1992-12-18 | 한동근 | Cosmetic composition |
JP2005526036A (en) * | 2002-02-19 | 2005-09-02 | シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト | Synergistic mixture of 1,2-alkanediol |
KR20120100891A (en) * | 2009-08-17 | 2012-09-12 | 아치 퍼스널 케어 프로덕츠, 엘.피. | Broad spectrum preservation blends |
JP5232656B2 (en) * | 2006-12-28 | 2013-07-10 | 株式会社マイクロバイオテック | Alkyl gallate pharmaceutical composition |
-
2013
- 2013-10-31 KR KR1020130131769A patent/KR102024947B1/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR920021130A (en) * | 1991-05-27 | 1992-12-18 | 한동근 | Cosmetic composition |
JP2005526036A (en) * | 2002-02-19 | 2005-09-02 | シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト | Synergistic mixture of 1,2-alkanediol |
JP5232656B2 (en) * | 2006-12-28 | 2013-07-10 | 株式会社マイクロバイオテック | Alkyl gallate pharmaceutical composition |
KR20120100891A (en) * | 2009-08-17 | 2012-09-12 | 아치 퍼스널 케어 프로덕츠, 엘.피. | Broad spectrum preservation blends |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10952956B2 (en) | 2016-06-27 | 2021-03-23 | Amorepacific Corporation | Antioxidant composition for skin |
KR102059043B1 (en) | 2018-11-21 | 2019-12-24 | 주식회사 에이조스바이오 | Antiseptic Composition |
Also Published As
Publication number | Publication date |
---|---|
KR102024947B1 (en) | 2019-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4852231B2 (en) | Synergistic mixture of 1,2-alkanediol | |
KR102043869B1 (en) | Synergistically acting ternary antimicrobial mixtures | |
JP2011074082A (en) | Antiseptic sterilizer and composition for application to human body | |
KR20150050234A (en) | Composition containing octyl gallate | |
KR102412958B1 (en) | Antibacterial or conservative composition containing polyglycerine-3 | |
KR101779131B1 (en) | A preservative for skin external application, and a cosmetic composition and a pharmaceutical composition comprising the same | |
EP3709955A1 (en) | Topical compositions | |
JP3774219B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP2005068095A (en) | Antiseptic fungicide and cosmetic, medicine and food compounded with antiseptic fungicide | |
JP2005213174A (en) | Antiseptic fungicide and cosmetic, medicine, and food compounded with the same | |
JP5013765B2 (en) | Antiseptic disinfectant, cosmetics, pharmaceuticals or foods containing the antiseptic disinfectant | |
KR102001257B1 (en) | Antibiotic composition containing ethylhexyl gallate | |
JP2005029535A (en) | Antiseptic bactericide, and cosmetic, medicine and food compounded therewith | |
KR101788179B1 (en) | Low irritation skin external application composition with an improved antiseptic ability | |
KR102260163B1 (en) | Antimicrobial Cosmetic Composition | |
JP4044005B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP2004300143A (en) | Antiseptic bactericidal agent, and the agent-compounded cosmetic, pharmaceutical and foodstuff | |
KR102037431B1 (en) | An antibacterial composition comprising plant extracts and the antiviral agent comprising the same | |
JP4294511B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
RU2660361C1 (en) | Preservative system | |
JP2005015361A5 (en) | ||
JP4294393B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP2007145748A (en) | Antiseptic sterilizer, cosmetic or medicine containing the antiseptic sterilizer, and method for antiseptic sterilization | |
BR112020000035A2 (en) | topical compositions | |
JP2005232011A (en) | Antiseptic sterilizer, and cosmetic, medicine and food compounded with the antiseptic sterilizer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20131031 |
|
PG1501 | Laying open of application | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20171213 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20131031 Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20190115 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20190828 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20190918 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20190918 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20220622 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20230627 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20240624 Start annual number: 6 End annual number: 6 |